Skip to main content
Purchase Recordings
ASHP LIVE! App
Conference Website
Browse Agenda
View Full Agenda
Browse by Title
Browse by Track
Browse by Category Topic
Browse By Date
Saturday, December 1, 2018
Sunday, December 2, 2018
Monday, December 3, 2018
Tuesday, December 4, 2018
Wednesday, December 5, 2018
Thursday, December 6, 2018
Sunday, December 8, 2019
Wednesday, December 11, 2019
Keyword Search
Presenters
Posters
Professional Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Federal Forum Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Student Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Resident Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Fellows Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Exhibitors
Browse by Company
Browse by Booth
Browse by Category
Floor Plan
Personnel Placement
Service (PPS)
Residency Showcase
Attendees
Login required
My Schedule
Login required
Login
Toggle navigation
Home
Purchase Recordings
ASHP LIVE! App
Conference Website
Browse Agenda
View Full Agenda
Browse by Title
Browse by Track
Browse by Category Topic
Browse By Date
Saturday, December 1, 2018
Sunday, December 2, 2018
Monday, December 3, 2018
Tuesday, December 4, 2018
Wednesday, December 5, 2018
Thursday, December 6, 2018
Sunday, December 8, 2019
Wednesday, December 11, 2019
Keyword Search
Presenters
Posters
Professional Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Federal Forum Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Student Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Resident Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Fellows Posters
Browse by Date / Time
Browse by Title
Browse by Number
Browse by Primary Author
Browse by Type
Browse by Category
Exhibitors
Browse by Company
Browse by Booth
Browse by Category
Floor Plan
Personnel Placement
Service (PPS)
Residency Showcase
Attendees
Login required
My Schedule
Login required
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Track
Browse by Track
Browse by Track
Type here to filter the list
Administrative Practice/Management/Financial Management/Human Resources
12-058 - Analysis and implementation of patient-specific insulin glargine syringes in the inpatient setting
Favorite
12-147 - Analysis of Controlled Substance Policy and Procedure at a Community Hospital and Comparison to Best Practice Guidelines
Favorite
9-187 - Assessing the financial feasibility of implementing clinical services at an independent pharmacy
Favorite
12-301 - Assessing the volume and rationale of telephone calls from hospital-based health-care providers to the hospital pharmacy: A quality improvement initiative
Favorite
10-192 - Assessment of Burnout within a Health-System Pharmacy Department
Favorite
13-344 - Automated Dispensing Cabinet optimization: medication utilization review to reduce costs and optimize inventory
Favorite
13-181 - Best practice direct oral anticoagulation process for early-directed deep vein thrombosis therapy to reduce admissions in a large community health care system
Favorite
13-101 - Booster breaks: the effect of pharmacy department work breaks on employee perspectives of coworker relationships
Favorite
12-098 - Comprehensive evaluation of USP 797 and 800 compliance after implementation of an IV workflow management system at an acute care teaching hospital
Favorite
11-377 - Cost saving opportunities for a non-profit community hospital to mitigate the effects of losing 340b
Favorite
13-388 - Cost savings associated with potential monoclonal antibody dose rounding at a large community teaching hospital
Favorite
11-076 - Creating a proposal to implement a specialty pharmacy within in a health system
Favorite
12-202 - Design, implementation, and assessment of an adverse event monitoring program within a self-funded prescription drug plan
Favorite
12-154 - Development and implementation of a statewide drug shortage network
Favorite
13-031 - Development of a visual dashboard for a specialty pharmacy
Favorite
12-267 - Effectiveness of injectable opioid preservation plan implemented in a major New York Academic Medical Center
Favorite
10-024 - Evaluating antibiotic selection for physician compliance with urinary tract infection electronic medical record (EMR) care pathways in a community hospital
Favorite
13-345 - Evaluation and improvement of processes related to intravenous product waste across a healthcare system
Favorite
12-030 - Evaluation of an oupatient-based, parmacist-led meds to beds program at a tertiary medical center in Los Angeles and a roadmap for expansion
Favorite
11-130 - Evaluation of burnout among hospital and health-system pharmacists in North Carolina
Favorite
12-416 - Financial impact of converting patients from warfarin to a direct oral anticoagulant (DOAC) at a rural federally qualified health center pharmacy
Favorite
9-298 - High-risk fall medication administration in relation to time of fall event in an inpatient hospital setting
Favorite
10-188 - Impact of 340B drug pricing on formulary decision making within a mixed-model health-system
Favorite
9-214 - Impact of pharmacy resident and pharmacy students on medication therapy management completion rate and reimbursement in an independent long-term care pharmacy serving assisted living facilities
Favorite
12-001 - Impact of Pharmacy-Led Medication Histories on Patient Outcomes
Favorite
11-335 - Implementation and cost savings analysis of an ambulatory pharmacy and therapeutics (P&T) committee with a standardized formulary in a rural health system
Favorite
10-430 - Implementation of a medication tracking tool to measure loss and waste in patient units of a community hospital
Favorite
13-033 - Implementing pharmacy-prepared unit-dose packaging of ophthalmic solutions for perioperative use across a health-system
Favorite
13-176 - Leveraging auto-verification to optimize pharmacist clinical activities
Favorite
13-343 - Medication use evaluation of rifaximin in a community hospital system
Favorite
13-149 - Patient counseling on high-risk medications to improve hospital consumer assessment of healthcare providers and systems (HCAHPS) scores and reduce hospital readmission rates
Favorite
10-100 - Pharmacy impact on narcotic overrides in a community hospital emergency department
Favorite
12-297 - Pharmacy Resident Led Multifocal Controlled Substances Diversion Prevention Program
Favorite
10-414 - Quantification of the financial impact caused by missing medications at UPMC Hamot
Favorite
10-087 - Retrospective evaluation of the cost and outcomes associated with appropriate and inappropriate antibiotic use in patients with asymptomatic bacteriuria in a community hospital
Favorite
9-264 - Standardizing workflow between four retail pharmacies at a Federally Qualified Health Center in Maine
Favorite
13-254 - The clinical impact of pharmacist intervention on prior authorization success rate at a University Call Center: a retrospective study
Favorite
10-187 - The Impact of Patient Financial Advocates on the Satisfaction and Affordability of Specialty Infusion Therapies
Favorite
10-219 - The implementation of safe workplace practices to insure compliance with USP General Chapter within a large healthcare system: Educating staff, assessing knowledge and compliance
Favorite
11-302 - Transitioning to a Decentralized Pharmacy Practice Model in a Tertiary Hospital
Favorite
10-323 - Use of the Delphi method in the development of a penicillin skin test protocol at a community hospital
Favorite
Ambulatory Care
9-119 - A retrospective cohort describing adherence rates to cardiovascular risk reduction guidelines in a single HIV clinic with an embedded pharmacist clinician providing metabolic disease management
Favorite
12-342 - Adherence to updated metformin dosing recommendations in a patient-centered medical home: a comparison of provider-pharmacist team vs. provider only approaches
Favorite
11-355 - Ambulatory antimicrobial stewardship for urinary tract infections: a pharmacist implementation study
Favorite
12-364 - An evaluation of patient factors that may impact hemoglobin A1c lowering in pharmacist-run collaborative drug therapy management clinics for type 2 diabetes
Favorite
12-146 - Analysis of services provided to geriatric home-bound patients enrolled in a program for primary care services in the home
Favorite
11-217 - Analyzing the hemoglobin A1C lowering effects of glucagon-like peptide-1 agonists in a population of West Virginia Medicaid patients
Favorite
10-442 - Anticoagulation control of vitamin-K antagonist in pharmacist-led clinic versus physician-led clinic
Favorite
10-094 - Assessing Barriers to Medication Adherence Among Residents of Jefferson County, Alabama
Favorite
10-113 - Assessing medication-related problems and their association with various patient, system, and clinical factors
Favorite
11-400 - Assessing pharmacist full time equivalents (FTE) for patient care demand in a team based primary care setting
Favorite
9-243 - Assessing the effect of continuous glucose monitoring (CGM) on medication adherence and glycemic control in patients with type 2 diabetes
Favorite
11-045 - Assessing the impact of pharmacist-led transition of care services in a primary health care center
Favorite
10-277 - Assessing the impact of translated prescription label directions for Nepalese refugee patients at a community pharmacy
Favorite
9-107 - Assessing the prevalence of diabetic retinopathy in well-controlled type 2 diabetes mellitus patients on fibrate therapy
Favorite
10-112 - Assessment of a newly initiated transitions of care clinic at an academic health center
Favorite
10-068 - Assessment of the ability of a gamified web-based application to identify opportunities for healthcare intervention in an ambulatory care pharmacy clinic setting
Favorite
9-057 - Assessment of the economic and clinical impact of an ambulatory care pharmacist position in an outpatient physician office
Favorite
9-272 - Automated referral to an ambulatory care pharmacist for patients recently hospitalized with a chronic obstructive pulmonary disease exacerbation: impact on 30-day hospital readmissions
Favorite
9-289 - Clinical outcomes of antibiotics use in patients with uncomplicated adult acute bronchitis
Favorite
13-354 - Collecting social determinants of health data and the link to cardiovascular disease risk and intervention: the PRAPARE tool
Favorite
9-436 - Community pharmacists' role in naloxone distribution during the post-operative period: a retrospective, single center, observational study
Favorite
12-164 - Comparing predictors of hospital readmission for high and highest risk patients
Favorite
9-049 - Comparison of glucagon-like peptide-1 receptor agonists versus insulin in combination with oral antidiabetics in patients with type 2 diabetes mellitus at an ambulatory care facility
Favorite
9-240 - Comparison of risk factors for vitamin D deficiency in patients with and without sickle cell disease at an urban ambulatory care clinic
Favorite
12-108 - Creation, Implementation, and Evaluation of Pharmacist-led Medicare Part D Open Enrollment Events
Favorite
10-144 - Deployment of clinical pharmacy services in a primary care physician group
Favorite
12-004 - De-prescribing: outcomes of a pharmacist-driven protocol for tapering benzodiazepines
Favorite
11-361 - Developing a pharmacy practice care model for managing medication therapy associated with endocrinology
Favorite
11-362 - Developing a pharmacy practice care model for proprotein convertase subtilsin-kexin type 9 (PCSK9) inhibitors
Favorite
13-411 - Development and implementation of an orientation program and longitudinal ambulatory care rotation for pharmacy residents
Favorite
12-015 - Digital medicines in chronic care management: using innovative technology to improve health outcomes in high-risk patients
Favorite
9-114 - Effect of a multidisciplinary team on clinical outcomes and medication burden in rural New Mexico
Favorite
12-191 - Effect of a pharmacist-led interdisciplinary dietary sodium intervention on blood pressure, sodium knowledge, and self-efficacy in patients with Stage 3 and 4 chronic kidney disease
Favorite
9-210 - Effect of a reporting system in managing appropriate use of direct-acting oral anticoagulants (DOACs) in the outpatient setting
Favorite
11-075 - Effectiveness of ambulatory care pharmacy management and interventions of a regional faith-based health care system
Favorite
12-339 - Effectiveness of implementing a medication therapy management program for improving adherence for patients in a community pharmacy
Favorite
10-238 - Effects of a comprehensive medication management clinic on high-risk medication use in the elderly
Favorite
11-350 - Evaluating pharmacist impact on new-start SSRI/SNRI adherence and therapy in adult patients in the primary care setting
Favorite
13-358 - Evaluating Quality of Care: Analysis of the impact of a clinical pharmacy program on the diabetes care of an underserved population within a medical home
Favorite
13-372 - Evaluating sacubitril/valsartan prescribing practices in patients with reduced ejection fraction heart failure
Favorite
9-185 - Evaluating the impact of influenza and streptococcal point of care testing and collaborative practice prescribing in a community pharmacy setting
Favorite
10-154 - Evaluating the impact of pharmacist-led interventions in an underserved diabetic population
Favorite
10-119 - Evaluating the impact of pharmacist-led interventions on smoking cessation in an established outpatient medication management clinic
Favorite
12-008 - Evaluation of a community hospital based pharmacist managed diabetes clinic
Favorite
9-129 - Evaluation of a pharmacist-driven transitions of care initiative and readmission rates in patients admitted with chronic obstructive pulmonary disease (COPD) exacerbation
Favorite
11-165 - Evaluation of amiodarone monitoring
Favorite
10-075 - Evaluation of an indigent care medication provision program on 30-day readmission rates in a community hospital
Favorite
9-290 - Evaluation of an interdisciplinary workflow for hypertension at a charity patient-centered medical home
Favorite
10-340 - Evaluation of appropriate prescribing and management of target specific oral anticoagulants (TSOACs) in an internal medicine clinic and the feasibility of expanding current anticoagulation services
Favorite
10-338 - Evaluation of appropriate prescribing of statin therapy based on ASCVD risk in CMR eligible patients
Favorite
10-206 - Evaluation of causes and treatment of subtherapeutic international normalized ratios (INRs)
Favorite
10-050 - Evaluation of COPD metrics for internal medicine clinic patients
Favorite
9-266 - Evaluation of direct oral anticoagulant use and implementation of a pharmacist-led direct oral anticoagulant telephone clinic in an outpatient federally qualified health center
Favorite
10-205 - Evaluation of elevated international normalized ratios (INRs) within a pharmacist-run, outpatient, anticoagulation service
Favorite
12-113 - Evaluation of Medication Management Potential of Pharmacists through Medicare Annual Wellness Visits
Favorite
11-242 - Evaluation of medication therapy management (MTM) interventions by clinical pharmacists in the ambulatory care setting
Favorite
10-310 - Evaluation of patient functional status improvement following participation in a pharmacist-guided, non-prescribing, multidisciplinary pain clinic
Favorite
10-162 - Evaluation of pharmacist involvement in chronic obstructive pulmonary disease inhaler education
Favorite
11-140 - Evaluation of pharmacist-managed diabetes mellitus under a collaborative clinical pharmacist practitioner agreement in a private rural clinic
Favorite
9-267 - Evaluation of pharmacotherapy in primary care and provider acceptance of treatment recommendations for patients with heart failure (HF)
Favorite
13-362 - Evaluation of pharmacy resident-led transitions of care service for patients with heart failure: a single center retrospective cohort study
Favorite
10-315 - Evaluation of prescribing practices of hormone replacement therapy in women 50 years and older with high cardiovascular risk at a federally qualified health center
Favorite
10-291 - Evaluation of proton pump inhibitor prescribing patterns in the underserved population
Favorite
11-161 - Evaluation of risk assessment and documentation for patients on chronic opioid therapy
Favorite
10-066 - Evaluation of the factors that predict non-participation in a diabetes prevention program
Favorite
13-371 - Evaluation of the prescribing practices of proton-pump inhibitors in patients with gastroesophageal reflux disease (GERD) and esophagitis in the outpatient setting
Favorite
9-263 - Expanding the use of pharmacist-managed insulin pumps in a primary care setting
Favorite
10-173 - Expansion of a transitions of care program in a large, academic pediatric hospital
Favorite
11-372 - Expansion of pharmacotherapy clinic services to include initiation, management, and monitoring of disease modifying treatments for patients with multiple sclerosis or rheumatoid arthritis
Favorite
9-197 - Exploring barriers to transition of care clinic visits in a post-stroke population
Favorite
11-401 - Identification of opportunities for pharmacist intervention for patients with uncontrolled hypertension in the adult primary care setting
Favorite
13-292 - Identifying osteoporosis care opportunities for pharmacist in a rural clinic setting
Favorite
12-101 - Impact assessment of a community pharmacy immunization service on vaccination rates and patient satisfaction in Puerto Rico
Favorite
9-040 - Impact of a clinical pharmacist on the management of diabetes mellitus in the ambulatory care setting of a large teaching hospital
Favorite
11-177 - Impact of a feedback toolkit for pharmacy preceptors to improve feedback and evaluation completion rates within an ambulatory care residency program
Favorite
10-280 - Impact of a first-month pharmacist consultation program on adherence to therapy in multiple sclerosis patients new to dimethyl fumarate in a specialty pharmacy setting
Favorite
9-115 - Impact of a formal training program for Advanced Practice Pharmacist Clinicians on continuous glucose monitoring utilization
Favorite
10-287 - Impact of a pharmacist and provider collaborative approach to improve initiation of statin therapy among patients with diabetes
Favorite
13-164 - Impact of a pharmacist-led diabetes management outpatient service in a rural senior community
Favorite
9-216 - Impact of a pharmacist-led transitions of care program on revenue and readmission rates in a hospital-owned outpatient provider system
Favorite
13-055 - Impact of a pharmacist-managed diabetes clinic on an underserved population with uncontrolled type 2 diabetes
Favorite
11-150 - Impact of a pharmacy-physician collaboration on asthma & chronic obstructive pulmonary disease on emergency department visits
Favorite
11-147 - Impact of a population health pharmacist within a health system
Favorite
9-281 - Impact of an ambulatory care pharmacist in psychiatric patient care
Favorite
9-183 - Impact of an ambulatory care pharmacist on outcomes in a family practice clinic
Favorite
11-289 - Impact of an ambulatory pharmacotherapy clinic in hemoglobin A1C reduction
Favorite
10-441 - Impact of clinical pharmacist-led diabetes management clinic on patient-related health outcomes at an academic tertiary hospital in Saudi Arabia: a prospective cohort study
Favorite
12-206 - Impact of group asthma education classes led by a multidisciplinary team in adults for asthma control
Favorite
12-173 - Impact of Pharmacist Driven Interventions on Inappropriate Antibiotic Prescribing for Upper Respiratory Tract Infections (URTIs) in a Family Medicine Residency Clinic
Favorite
11-049 - Impact of pharmacist intervention on health services utilization and cost for diabetic patients
Favorite
9-253 - Impact of pharmacist intervention on hemoglobin A1c in patients with uncontrolled diabetes in rural primary care clinics: a retrospective chart review
Favorite
11-305 - Impact of pharmacist intervention on pneumococcal conjugate vaccine – 13 valent vaccination rates in a family practice residency clinic
Favorite
11-395 - Impact of pharmacist involvement in interdisciplinary transitions of care in the primary care setting
Favorite
11-208 - Impact of pharmacist involvement in transitional care management
Favorite
12-003 - Impact of pharmacist-led medication reconciliation on drug-related problems and potentially avoidable readmissions in Medicare Advantage patients discharged from the emergency department
Favorite
10-149 - Impact of pharmacist-led medication review on chronic obstructive pulmonary disease (COPD) 30-day readmission rates in the ambulatory care setting
Favorite
11-109 - Impact of pharmacists' intervention on reducing readmission rates and mortality in a community hospital congestive heart failure clinic
Favorite
13-019 - Impact of pharmacist’s intervention with proton pump inhibitor (PPI) prescribing and deprescribing in a primary care setting
Favorite
12-014 - Impact of pharmacists on medication adherence and prevention of hospital utilizations in an ambulatory care setting
Favorite
10-012 - Impact of pharmacists on meeting diabetes preventative care measures in community health system outpatient clinics: a matched cohort analysis
Favorite
12-325 - Impact of pharmacotherapy services on lipid management in diabetic patients
Favorite
13-228 - Impact of pharmacy services at an outpatient cardiology clinic
Favorite
11-004 - Impact of physician-pharmacist collaboration for disease state management on patient outcomes
Favorite
11-402 - Impact of shared medical appointments with a cardiologist and pharmacist on the pharmacologic management of heart failure
Favorite
11-034 - Impact of vitamin D on pulmonary outcomes and bone health in patients with cystic fibrosis
Favorite
13-307 - Implementation and evaluation of a chronic obstructive pulmonary disease (COPD) pharmacy-managed clinic in southeastern Kentucky
Favorite
10-059 - Implementation and evaluation of a patient-centered diabetes education program based on patient preferences
Favorite
10-153 - Implementation and evaluation of a pharmacist-driven chronic obstructive pulmonary disease care bundle at a community hospital
Favorite
9-277 - Implementation of a clinical pharmacist driven medication therapy management (MTM) program for uncontrolled hypertension and cholesterol
Favorite
13-137 - Implementation of a Pharm.D. run medication management clinic in the outpatient setting, targeting high-risk Congestive-Heart-Failure (CHF) patients and impact on admissions/readmissions and emergency-department (ED) utilization
Favorite
11-370 - Implementation of a pharmacist-led opioid stewardship program in an ambulatory care setting
Favorite
11-351 - Implementation of a pharmacist-led smoking cessation program in a pulmonology specialty clinic
Favorite
10-120 - Implementation of a rolling cycle of patient evaluation and education sessions focused on diabetes-related comorbidities in a pharmacist-run ambulatory care clinic
Favorite
11-388 - Implementation of an ambulatory clinical pharmacist playbook
Favorite
9-024 - Implementation of comprehensive medication management review in the ambulatory care setting
Favorite
10-284 - Implementation of pharmacist medication services for heart failure patients
Favorite
9-147 - Implementation of pharmacist-led oral chemotherapy education in an outpatient oncology clinic
Favorite
9-392 - Implementation of standard documentation to capture clinical pharmacists’ interventions in a pre-specified elderly population with severe frailty
Favorite
11-299 - Implementing a pharmacist-led benzodiazepine deprescribing protocol in an outpatient primary care clinic
Favorite
13-291 - Improvement of diabetes management through health registry surveillance
Favorite
11-243 - Improving Efficiency through Optimizing Workflow in a Pharmacist-Run Diabetes Clinic
Favorite
9-029 - Improving the gaps in home medication reconciliation process by implementing standardized education for nurses
Favorite
9-323 - Increasing naloxone knowledge and use through direct-to-consumer education
Favorite
11-278 - Interventions to improve work efficacy and decrease burnout of ambulatory care pharmacists
Favorite
13-252 - Measuring compliance with the diabetes composite quality performance benchmark in a primary care-based accountable care organization: Examining HgA1c goals and diabetic eye exams
Favorite
11-144 - Medication discrepancies at hospital discharge in patients with type 1 and type 2 diabetes on insulin
Favorite
11-112 - Medication use evaluation – safe and effective use of benzodiazepines in the elderly population of a primary care setting
Favorite
13-253 - Meeting the measures: Statin use in diabetic patients in a primary care-based accountable care organization
Favorite
12-375 - Multicenter retrospective cohort study evaluating antibiotic prescribing patterns for the treatment of urinary tract infections (UTIs) in primary care
Favorite
11-141 - Optimization of the warfarin management process in a rural primary care clinic
Favorite
11-393 - Optimizing the pharmacist’s role in a multidisciplinary patient centered chronic pain focused visit
Favorite
12-028 - Outcomes of a pharmacist-managed psoriasis service
Favorite
12-341 - Outcomes of a pharmacy-driven transitions-of-care program within a patient-centered medical home
Favorite
13-204 - Outpatient antimicrobial utilization for upper respiratory conditions
Favorite
10-166 - Patient preferences regarding vaccinations administered by pharmacists vs registered nurses at MetroHealth outpatient clinics
Favorite
10-324 - Patient Risk Stratification to Facilitate Pharmacist Provision of Chronic Care Management Services
Favorite
9-265 - Pharmacist assisted intervention for patients diagnosed with Alcohol Use Disorder in an integrated primary care setting
Favorite
13-357 - Pharmacist impact on chronic obstructive pulmonary disease (COPD) in a transitions of care pilot program
Favorite
10-296 - Pharmacist impact on Medicare star ratings for adherence and high risk medication use in the elderly
Favorite
10-014 - Pharmacist impact on obtaining and maintaining diabetes control in a community health system
Favorite
9-435 - Pharmacist management of hypertension in an outpatient clinic
Favorite
12-371 - Pharmacist-developed opioid overdose education and naloxone distribution program in the emergency department of a community hospital: a pilot study
Favorite
12-318 - Pharmacist-managed asthma clinic for 9/11 responders: a pilot study
Favorite
10-228 - PHARM-HF: Effect of pharmacist interventions in an outpatient clinic on 30-day readmission rates for heart failure
Favorite
10-132 - Predictors of 30-day readmission in family medicine patients to identify candidates for transitional care management (TCM) services
Favorite
10-410 - Pre-exposure prophylaxis (PrEP) education and utilization in an urban family medicine health center
Favorite
10-167 - Prescribing practices for type 2 diabetes mellitus: results of an online survey
Favorite
9-382 - Prescribing Trends of Sulfonylureas versus Other Non-Insulin Antidiabetic Agents in the United States from 2009 to 2015
Favorite
12-346 - Project PACT-STROKE: Pharmacists Act on Care Transitions for Stroke
Favorite
11-454 - Retrospective chart review comparing a pharmacy-run conservative dosing protocol to manufacturer guidelines for U-100 to U-500R insulin conversions
Favorite
11-038 - Retrospective Review on Outcomes of Proton-Pump Inhibitor Deprescribing in Medication Therapy Management Patient Population
Favorite
11-419 - Reviewing current outpatient practices regarding serum potassium monitoring following aldosterone antagonist initiation
Favorite
12-211 - Role of Pharmacists within a Value-based Healthcare Model
Favorite
13-121 - Specialty pharmacy: reducing barriers to treatment initiation- a review of internal workflow processes
Favorite
9-274 - Standardized referral of at-risk hospitalized patients for pharmacist-driven comprehensive medication management in a comprehensive primary care plus clinic: analysis of 30-day hospital readmissions
Favorite
13-356 - Surveying Kentucky pharmacists’ perspective and barriers on providing post-exposure prophylaxis therapy
Favorite
11-091 - Targeted strategies to improve population health in a rural community
Favorite
9-268 - The impact of a pharmacist-led smoking cessation clinic in a fully integrated federally qualified health center serving the homeless or those with housing insecurity
Favorite
13-262 - The Impact of Motivational Interviewing on Chronic Kidney Disease Identification and Management in Patients with Diabetes Mellitus and Low Socioeconomic Status
Favorite
10-247 - The impact of University Hospitals Specialty Pharmacy hepatitis C patient management program on patient and pharmacy outcomes
Favorite
11-273 - Use of a student-driven centralized service to improve adherence rates
Favorite
11-432 - Use of sacubitril/valsartan for heart failure with reduced ejection fraction (HFrEF) in a safety net population
Favorite
10-421 - Utilization of three metformin extended release formulations in an urban family medicine residency program
Favorite
Cardiology/Anticoagulation
10-273 - A quality assessment of direct oral anticoagulants in an academic medical center
Favorite
10-299 - A retrospective study to evaluate the impact of sacubitril/valsartan on disease-related outcomes of heart failure patients within an Oregon health-system
Favorite
13-301 - Adenosine vs. regadenoson: a post-marketing comparison of side effects, cost, and time taken to perform cardiac stress testing: is regadenoson worth the extra cost?
Favorite
13-171 - Alternative alteplase dosing strategies in the ekosonic endovascular system procedure for treatment of pulmonary embolism
Favorite
11-437 - Alternative thromboprophylactic dosing of enoxaparin: a retrospective analysis evaluating the need for dose adjustments in obesity
Favorite
9-346 - Amiodarone for atrial fibrillation: staying on beat with patient safety
Favorite
12-357 - An Evaluation of Vitamin K (Phytonadione) Dosing Practices: Defining the Pharmacist’s Role on Appropriate Dosing and Cost-saving Initiatives
Favorite
13-193 - An interdisciplinary initiative to increase inpatient and emergency department prescribing of direct oral anticoagulants for patients with venous thromboembolism: a multisite evaluation
Favorite
12-376 - Analysis of Heparin Monitoring Protocol Utilizing the Activated Partial Thromboplastin Time vs Anti-factor Xa in an Academic Medical Center
Favorite
9-207 - Analysis of the time to administration and accuracy of dosing of 4-factor prothrombin complex concentrate at an academic medical center
Favorite
11-215 - Apixaban and rivaroxaban versus warfarin for the treatment of venous thromboembolism in obese patients
Favorite
9-149 - Assessing readmission rates for thrombosis in patients discharged on anticoagulation therapy after elective total hip or knee arthroplasty
Favorite
13-053 - Assessing the prescribing of direct oral anticoagulants compared to warfarin in patients with extremes in body weight
Favorite
9-307 - Assessing venous thromboembolism prophylaxis in the liver cirrhosis patient population at a large academic medical center
Favorite
11-172 - Assessment of direct thrombin inhibitor use in heparin-induced thrombocytopenia
Favorite
13-179 - Assessment of heparin dosing strategies in the cardiac catherization lab for coronary interventions
Favorite
12-397 - Assessment of multiple variables regarding the correlation between heparin dose and activated clotting time (ACT) in percutaneous vascular intervention angiography
Favorite
11-085 - Assessment of prescribing patterns of direct oral anticoagulant medications pre- and post- implementation of a pharmacist-led dosing tool
Favorite
12-383 - Assessment of prescribing patterns of venous thromboembolism prophylaxis after quality improvement interventions at a large, tertiary care, academic medical center: phase 3 of 3
Favorite
12-130 - Assessment of venous thromboembolism (VTE) prophylaxis strategies in underweight patients
Favorite
12-232 - Assessment of warfarin and unfractionated heparin overlap in patients with confirmed venous thromboembolism
Favorite
12-157 - Association between warfarin time in therapeutic range and post-transplant outcomes in heart transplant recipients
Favorite
9-097 - Attainment of therapeutic anti-factor Xa levels in morbidly obese patients receiving enoxaparin
Favorite
12-087 - Cangrelor use in an academic medical center: extending beyond the FDA indication
Favorite
12-102 - Caving Under Pressure: Management of Hypertensive Crisis
Favorite
9-021 - Characterization of anticoagulation with ventricular assist devices at a single center
Favorite
12-194 - Cirrhosis, thrombosis, finding faXts about doses: dosing of unfractionated heparin for venous thromboembolism in cirrhosis
Favorite
13-161 - Clinical Effects of Coaguchek XS PT Test Strips Calibration on Anticoagulation Management Services
Favorite
9-082 - Comparison of a fixed-dose 4 factor PCC dosing regimen to a weight based regimen for warfarin associated bleeding in a community hospital
Favorite
10-209 - Comparison of anti-factor Xa and activated partial thromboplastin time protocols for unfractionated heparin monitoring at a tertiary hospital
Favorite
13-334 - Comparison of hemostatic outcomes in anticoagulated patients receiving fixed dose versus weight based 4-factor prothrombin complex concentrate
Favorite
10-371 - Comparison of high and low intensity heparin protocols on anticoagulation related complications in patients undergoing extracorporeal membrane oxygenation
Favorite
10-029 - Comparison of pharmacist versus prescriber 4T score calculation and HIT antibody results
Favorite
10-321 - Comparison of postoperative complications after total hip or total knee arthroplasty in patients receiving prophylactic antithrombotic agents in a community hospital setting
Favorite
10-001 - Comparison of two heparin protocols for use in extended percutaneous mechanical circulatory support
Favorite
9-218 - Describing current practices of pharmacist-driven dose adjustment of prophylactic enoxaparin in medically-ill, obese patients at an academic medical center
Favorite
10-051 - Designing a comparison study evaluating discharge diuretic dosing and all-cause thirty-day readmission rates in acute decompensated heart failure patients
Favorite
11-344 - Development of a Comprehensive Anticoagulant Reversal Protocol for a Health System
Favorite
13-132 - Does renal function affect the safety of direct oral anticoagulants for stroke prevention in atrial fibrillation?
Favorite
11-092 - Door-to-diuretic time in patients presenting with acute decompensated heart failure (ADHF) and the impact of pharmacist-initiated heart failure patient education at an inner city hospital
Favorite
9-357 - Effect of adjusted or actual body weight in creatinine clearance calculation on the rates of dofetilide discontinuation or dose reduction during dofetilide initiation
Favorite
12-192 - Effect of digoxin on right ventricular function in patients with left ventricular assist devices
Favorite
13-336 - Effect of intensive lifestyle changes on medication therapy for coronary heart disease
Favorite
12-089 - Effect of peri-procedural heparin versus bivalirudin on bleeding in patients receiving cangrelor for percutaneous coronary intervention at an academic medical center
Favorite
10-047 - Effect of renin-angiotensin-aldosterone antagonists and beta blockers on cardiac reverse remodeling after transcatheter aortic valve replacement for severe aortic stenosis
Favorite
9-442 - Effect on Patient Outcomes and Cost Savings After Implementation of a Prothrombin Complex Concentrate (Human)® Dose Standardization and Restricted Use Protocol
Favorite
11-200 - Effectiveness and safety of metolazone dosing in combination with loop diuretic therapy in acute decompensated heart failure
Favorite
11-204 - Effects of intravenous morphine administration on readmission rates during acute myocardial infarction in a community hospital
Favorite
13-221 - Efficacy and safety of systemic heparin and bivalirudin in adult patients supported by extracorporeal membrane oxygenation
Favorite
13-102 - Efficacy of established direct oral anticoagulants in obese patients
Favorite
9-424 - Efficacy of heparin protocols with and without boluses
Favorite
10-025 - Efficacy of twice-daily aspirin versus direct-acting oral anticoagulants for the prevention of deep venous thrombosis and pulmonary embolism after orthopedic surgery
Favorite
9-411 - Evaluating argatroban use and a rapid laboratory test to detect heparin-induced thrombocytopenia: a pharmacy and laboratory collaboration
Favorite
13-112 - Evaluating Direct Oral Anticoagulant Prescribing Practices and Impact on Patient Outcomes
Favorite
9-038 - Evaluating the appropriateness of enoxaparin dosing for venous thromboembolism prophylaxis in obese patients
Favorite
9-308 - Evaluating the characteristics and outcomes of prescribing practices of direct oral anticoagulants vs. vitamin K antagonist for therapeutic anticoagulation in obese patients
Favorite
12-124 - Evaluating the clinical interpretation of the anti-platelet factor 4 assay (PF4 ELISA) in the absence of reported optical density units
Favorite
9-233 - Evaluating the dual impact of dose and time to administration of IV loop diuretics in acute heart failure patients
Favorite
9-249 - Evaluating the outcomes associated with adjusted enoxaparin dosing versus non-adjusted enoxaparin dosing in obese patients requiring therapeutic anticoagulation
Favorite
9-413 - Evaluating the safety and efficacy of direct oral anticoagulants (DOACs) in patients weighing over 120 kilograms
Favorite
13-395 - Evaluating the safety and efficacy of pharmacist and physician dosing and monitoring of warfarin at a three-campus community hospital
Favorite
11-052 - Evaluating the safety and efficacy of transitioning from a fixed-dose protocol to a weight-based protocol for heparin infusion and titration
Favorite
9-055 - Evaluating the safety of anticoagulation in thrombocytopenia
Favorite
11-058 - Evaluating the safety of catheter-directed thrombolysis in patients with deep vein thrombosis, pulmonary embolism, peripheral arterial disease, or peripheral vascular disease
Favorite
12-374 - Evaluating the use of QT prolonging medications in hospitalized patients
Favorite
12-125 - Evaluating use of direct oral anticoagulants (DOACs) in patients with cardiac thrombus
Favorite
10-064 - Evaluation of 4-factor prothrombin complex concentrate administration
Favorite
9-258 - Evaluation of a bivalirudin dosing nomogram for heparin-induced thrombocytopenia
Favorite
11-188 - Evaluation of acute care patients previously taking oral factor Xa inhibitors and experiencing lab interference when transitioning to parenteral anticoagulation
Favorite
11-222 - Evaluation of adherence rates of guideline-directed management and therapy (GDMT) using current guidelines for the management of heart failure
Favorite
10-252 - Evaluation of an amiodarone dosing strategy for the prevention of postoperative atrial fibrillation at an academic medical center
Favorite
12-270 - Evaluation of an unfractionated heparin dosing protocol in obese patients: a retrospective review
Favorite
9-255 - Evaluation of anticoagulation in patients with atrial fibrillation admitted with acute ischemic stroke
Favorite
12-382 - Evaluation of anticoagulation practices with a percutaneous ventricular assist device
Favorite
10-409 - Evaluation of apixaban and rivaroxaban effectiveness in stroke prevention in morbidly obese atrial fibrillation patients
Favorite
12-111 - Evaluation of apixaban utilization in hemodialysis patients with atrial fibrillation
Favorite
13-380 - Evaluation of bivalirudin anticoagulation in patients receiving extracorporeal membrane oxygenation at an academic medical center
Favorite
11-309 - Evaluation of bleeding and thrombotic risk in patients receiving triple antithrombotic therapy
Favorite
13-248 - Evaluation of direct oral anticoagulant (DOAC) treatment failure and associated risk factors in patients with class III obesity
Favorite
9-091 - Evaluation of direct oral anticoagulants in obese and extremely obese patients
Favorite
10-090 - Evaluation of diuretic dose modification at discharge and 30-day readmission rate in heart failure with preserved ejection fraction
Favorite
13-247 - Evaluation of Erythropoietin Stimulating Agents (ESAs) and its efficacy on blood optimization for cardiothoracic surgery
Favorite
11-254 - Evaluation of fixed-dose four-factor prothrombin complex concentrate within a community health system
Favorite
12-279 - Evaluation of four-factor prothrombin complex concentrate use in patients with chronic liver disease
Favorite
11-234 - Evaluation of heparin drips in obese patients at an academic medical center
Favorite
9-122 - Evaluation of native state thrombophilia testing within an academic teaching hospital
Favorite
11-066 - Evaluation of pharmacist counseling for heart failure patients on readmissions at a community teaching hospital
Favorite
11-186 - Evaluation of pharmacist review of direct oral anticoagulants in the inpatient setting
Favorite
10-434 - Evaluation of Pharmacist-managed anticoagulation clinic compared to Hematologist-managed anticoagulation Clinic in a Tertiary Hospital in Saudi Arabia
Favorite
10-233 - Evaluation of Pharmacy recommended anticoagulation post orthopedic surgery for patients who were on direct oral anticoagulation or warfarin prior to surgery
Favorite
12-204 - Evaluation of prescribing patterns of direct oral anticoagulants at an academic medical center
Favorite
11-013 - Evaluation of prophylactic enoxaparin dosing in morbidly obese patients at an integrated healthcare system
Favorite
12-224 - Evaluation of Recombinant Factor VIIa dose for perioperative bleeding in patients requiring cardiopulmonary bypass
Favorite
13-075 - Evaluation of Regadenoson Utilization at a Community Teaching Hospital
Favorite
12-296 - Evaluation of sacubitril/valsartan utilization in a teaching hospital
Favorite
12-042 - Evaluation of sacubitril/valsartan’s effect on hemoglobin A1C, ejection fraction, and/or psychological issues in patients with congestive heart failure at a multidisciplinary clinic
Favorite
13-290 - Evaluation of subcutaneous heparin utilization for venous thromboembolism prophylaxis in hospitalized obese patients
Favorite
13-376 - Evaluation of the appropriate use of statins in patients hospitalized for acute coronary syndrome at a community hospital
Favorite
11-063 - Evaluation of the concomitant use of direct oral anticoagulants and strong CYP3A4/P-gp inducers or inhibitors
Favorite
9-168 - Evaluation of the effectiveness of heparin dosing protocol in patients with Impella devices
Favorite
12-009 - Evaluation of the Efficacy and Safety of Alteplase for the Treatment of Pulmonary Embolism
Favorite
10-245 - Evaluation of the impact of achieving at least 50 percent of target doses of select beta blockers in patients with heart failure on hospitalizations
Favorite
13-050 - Evaluation of the management of intravenous unfractionated heparin infusions using percentage of partial thromboplastin times in the therapeutic range
Favorite
10-226 - Evaluation of the safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease
Favorite
12-137 - Evaluation of the transitioning process between parenteral unfractionated heparin products and direct oral anticoagulants at the Henry Ford Health System
Favorite
12-242 - Evaluation of the Use of Loop Diuretic Dosage Adjustments After Initiation of Angiotensin-Neprilysin Inhibitor in Heart Failure Patients
Favorite
12-205 - Evaluation of therapeutic enoxaparin dosing on anti-Xa levels in obese patients
Favorite
11-293 - Evaluation of thromboembolic events after implementation of the Padua Prediction Score (PPS) among a general medicine patient population
Favorite
13-023 - Evaluation of time in therapeutic range and major adverse events due to warfarin experienced by patients in a pharmacist-run anticoagulation clinic
Favorite
9-433 - Evaluation of weight-based versus flat loading dosing of digoxin
Favorite
10-290 - Factors associated with direct oral anticoagulant (DOAC) treatment failure
Favorite
9-429 - Factors associated with inappropriate inpatient apixaban prescribing practices
Favorite
10-388 - Feasibility of therapeutic unfractionated heparin monitoring utilizing anti-factor Xa compared to activated partial thromboplastin time
Favorite
13-281 - Fixed versus weight-based dosing of 4- factor prothrombin complex concentrate for the reversal of vitamin-k antagonist: a multi-center, retrospective analysis
Favorite
13-258 - Fixed-dose activated prothrombin complex concentrate (aPCC) for oral factor Xa inhibitor reversal
Favorite
10-270 - Guideline-directed medical therapy in long-term care facility patients with heart failure
Favorite
10-079 - Heparin management for the Impella ventricular assistance device
Favorite
10-033 - Heparin Resistance: Identification of Risk Factors
Favorite
11-292 - Identification of risk factors contributing to venous thromboembolism (VTE) after orthopedic trauma and utilization of a standardized VTE prophylaxis algorithm for orthopedic trauma patients
Favorite
12-381 - Impact of a novel specialty pharmacy referral program on direct oral anticoagulant (DOAC) prescribing and patient satisfaction
Favorite
9-011 - Impact of a pharmacist-managed direct oral anticoagulation stewardship program: a pilot study
Favorite
11-028 - Impact of a pharmacy-led anticoagulant and antiplatelet medication counseling program in an acute care hospital
Favorite
13-270 - Impact of an inpatient pharmacist-managed warfarin maintenance protocol on time in therapeutic range
Favorite
12-245 - Impact of audio/visual medication counseling in patients’ native languages on understanding of anticoagulant medications
Favorite
9-108 - Impact of body mass index (BMI) on 90-day warfarin requirements: a retrospective chart review
Favorite
11-303 - Impact of heart failure transitions of care program: a prospective study of heart failure education and patient satisfaction
Favorite
13-265 - Impact of implementing a periprocedural protocol for the management of antithrombotic agents in an acute care community hospital
Favorite
12-248 - Impact of pharmacist intervention on medication literacy and adherence in cardiac patients
Favorite
13-014 - Impact of pharmacist interventions for heart failure patients with reduced left ventricular ejection fraction in a community-based teaching hospital
Favorite
12-062 - Impact of switching poorly controlled patients on warfarin to rivaroxaban – focus on adherence and workflow
Favorite
13-096 - Impact of using a congestive heart failure electronic scoring tool: an assessment of 30 day readmission rates
Favorite
12-132 - Implementation and evaluation of a direct oral anticoagulant (DOAC) management service in the anticoagulation clinic
Favorite
11-340 - Implementing a pharmacokinetic (based on anti-factor Xa) adjusted enoxaparin dosing protocol for Trauma patients
Favorite
11-318 - Incidence of heparin-induced thrombocytopenia at a 443-bed acute care hospital
Favorite
11-203 - Incidence of postoperative atrial fibrillation associated with the use of dopamine after cardiac surgery
Favorite
12-403 - Incidence of successful supraventricular tachycardia induction with epinephrine versus isoproterenol for patients undergoing ablation therapy in the electrophysiology laboratory
Favorite
10-026 - Incidence of thrombotic events in obese patients treated with direct-acting oral anticoagulants (DOACs)
Favorite
10-356 - Incidence of venous thromboembolism (VTE) after administration of prothrombin complex concentrate (human)
Favorite
11-106 - Is heparin per pharmacy better at achieving therapeutic levels than nursing using a nomogram?
Favorite
12-226 - Low intensity heparin infusion bleed risk and outcomes analysis
Favorite
11-256 - Medication use evaluation of human 4-factor prothrombin complex concentrate
Favorite
9-230 - Methylprednisolone in addition to beta-blocker or amiodarone for prevention of postoperative atrial fibrillation (POAF) in coronary artery bypass graft surgery (CABG)
Favorite
11-346 - Monitoring and adjusting unfractionated heparin infusions for patients previously on oral factor Xa inhibitors
Favorite
13-260 - Nicardipine versus clevidipine and nitroprusside for postoperative hypertension after open heart surgery
Favorite
13-143 - Ongoing evaluation of the impact of a post-operative atrial fibrillation prevention protocol for patients undergoing cardiothoracic surgery
Favorite
11-074 - Optimization and standardization of heparin infusion protocols across a state-wide hospital system: a retrospective analysis to determine factors influencing time in therapeutic range
Favorite
13-285 - Outcomes after use of four-factor prothrombin complex concentrate for reversal of DOAC-associated bleeding
Favorite
9-426 - Outcomes Associated with Optimization of Guideline Directed Medical Therapy (GDMT) in Patients Admitted for an Acute Heart Failure Exacerbation
Favorite
11-327 - Outcomes of an Inpatient Pharmacist-Driven Warfarin Protocol in a Community Hospital Setting
Favorite
10-451 - Outcomes with rivaroxaban as a part of triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
Favorite
12-263 - Periprocedural Interruption of Direct Oral Anticoagulants for Percutaneous Coronary Intervention
Favorite
13-251 - Pharmacist Driven Medication Reconciliation Program Targeted to Patients with a Primary Diagnosis of Acute Decompensated Heart Failure
Favorite
12-293 - Platelet function p2Y12 testing use in assessing the risk for hemorrhage in patients on clopidogrel
Favorite
11-168 - Post-operative venous thromboembolism (VTE) prophylaxis in total hip and total knee arthroplasty
Favorite
12-278 - Prescribing pattern and appropriateness of anticoagulation in new onset non-valvular atrial fibrillation in hospitalized older adults
Favorite
11-162 - Readmission Rates in Patients Receiving Triple Antithrombotic Therapy
Favorite
12-343 - Real-world experience with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors at a university specialty pharmacy
Favorite
9-124 - Retrospective analysis of an antithrombosis de-escalation protocol in a pharmacist-run, hospital-based clinic
Favorite
11-436 - Retrospective analysis of the safety and efficacy of a reduced infusion rate heparin protocol for the treatment of venous thromboembolism
Favorite
9-164 - Retrospective analysis of weight-based versus standard dose diltiazem in the acute treatment of atrial fibrillation in a community hospital
Favorite
9-051 - Retrospective evaluation of remote dielectric sensing (ReDS) vest technology and its impact on heart failure readmission rates and diuretics therapy
Favorite
13-243 - Retrospective medication use evaluation of continuous heparin infusions in a community hospital setting
Favorite
13-144 - Retrospective review of patients treated with argatroban for heparin induced thrombocytopenia
Favorite
11-017 - Retrospective review of the evaluation and treatment of patients with suspected heparin-induced thrombocytopenia
Favorite
10-156 - Retrospective study of an unfractionated heparin dosing protocol in venous thromboembolism in the morbidly obese
Favorite
9-138 - Review of appropriate dosing of direct oral anticoagulants
Favorite
12-047 - Review of outcomes using 4-factor prothrombin complex concentrate fixed dosing regimen versus standard dosing
Favorite
9-384 - Review of the outcomes data on the use of direct oral anticoagulation in solid organ transplant patients
Favorite
12-353 - Safety and effectiveness of accelerated intravenous sodium ferric gluconate complex administration in heart failure patients
Favorite
12-333 - Safety and effectiveness of fixed dose four-factor prothrombin complex concentrate at a 351-bed community hospital
Favorite
9-078 - Safety and efficacy of apixaban in patients with venous thromboembolism and end-stage renal disease
Favorite
12-239 - Safety and efficacy of Kcentra for the reversal of oral factor Xa inhibitor-associated bleeding
Favorite
12-365 - Safety outcomes of a new anticoagulation management service for patients on novel anticoagulants, a pre- and post-interventional analysis
Favorite
12-144 - Single-center retrospective analysis evaluating the safety and efficacy of a pharmacist-managed inpatient warfarin dosing service
Favorite
11-230 - Sotalol monitoring during initiation of therapy
Favorite
13-167 - Standardization of enoxaparin dose to 40mg daily in post-operative orthopedic patients
Favorite
9-201 - System-wide evaluation of sotalol use
Favorite
13-359 - Target-specific oral anticoagulant use in morbid obesity and rates of venous thromboembolism and stroke
Favorite
9-315 - The effect of an integrated heparin calculator on time to therapeutic activated partial thromboplastin time (aPTT)
Favorite
10-092 - The efficacy and safety of non-vitamin K oral anticoagulants following cardiac valve replacement
Favorite
9-128 - The Impact of Oral Diuretic Transition Prior to Hospital Discharge on Heart Failure Readmission Rates
Favorite
10-440 - The pattern of direct oral anticoagulant use in Saudis' clinical practice, a retrospective cross sectional descriptive study
Favorite
9-127 - Timing of initial intravenous loop diuretic dose in heart failure exacerbation
Favorite
13-177 - Use of apixaban in valvular atrial fibrillation in cardiothoracic surgical patients
Favorite
13-057 - Use of direct oral anticoagulants compared to warfarin in the obese population
Favorite
10-241 - Use of intravenous iron in patients admitted with heart failure
Favorite
11-274 - Use of warfarin versus direct oral anticoagulants in obese individuals for the treatment of venous thromboembolism: a retrospective chart review
Favorite
13-062 - Utilization of rivaroxaban in overweight/obese patients at Cook County Hospital and Healthcare System (CCHHS)
Favorite
10-021 - Venous thromboembolism (VTE) occurrence in obese patients versus non-obese patients taking direct oral anticoagulants (DOACs)
Favorite
12-338 - Venous thromboembolism prophylaxis usage at a community teaching hospital
Favorite
Chronic/Managed Care
9-239 - Acceptance of pharmacist-recommended inhaled corticosteroids by primary care providers managing pediatric Medicaid beneficiaries in a managed care organization
Favorite
10-268 - Acute exacerbations of asthma and chronic obstructive pulmonary disease management: a look at outcomes with ipratropium/albuterol dosing frequencies of “around the clock†versus “while awakeâ€
Favorite
11-252 - Assessing the impact of medication compliance packaging on hemoglobin A1c in diabetic patients receiving oral antiglycemic medications
Favorite
12-120 - Clinical outcomes of switching patients to preferred short-acting/rapid-acting insulin products among a commercially insured population
Favorite
9-362 - Effect of telephonic first-fill counseling for medications received via home delivery on adherence and patient satisfaction in a community pharmacy setting
Favorite
9-316 - Effects of prescribing COPD rescue kits on hospital readmissions
Favorite
12-026 - Eradication of hepatitis C virus: how does this affect glycemic control in patients with type 2 diabetes mellitus?
Favorite
12-099 - Evaluate the clinical effectiveness of an interdisciplinary collaborative care in poor controlled diabetes type 2 patients
Favorite
10-386 - Evaluating the impact of a nurse case manager-led program on a hemophilia population
Favorite
9-269 - Impact of a Medicare Advantage (MA) chronic condition special needs plan (C-SNP) on medication adherence and health care utilization outcomes
Favorite
10-278 - Impact of a medication synchronization program on medication adherence and clinical outcomes in a refugee population
Favorite
12-044 - Impact of anti-tumor necrosis factor (TNF) therapy site of care on inflammatory bowel disease outcomes in adults and children
Favorite
11-251 - Implementation and evaluation of comprehensive education of diabetes to improve statin therapy initiation in diabetic patients
Favorite
10-380 - Implementation of a pharmacist-led transitions of care (TOC) program for chronic obstructive pulmonary disease (COPD) in a community teaching hospital
Favorite
10-385 - Long-acting insulin formulary change and impact on health care utilization and cost in a Medicaid population
Favorite
12-022 - Oncology Bundled Payment Model: Adherence to Recommended Cancer Treatment Pathways and Drug Utilization in an Independent Practice Association (IPA)
Favorite
11-342 - Patient Characteristics Impacting the Utilization of MyChart Messaging: A Descriptive Analysis
Favorite
13-414 - Pharmacist led cost effectiveness intervention analysis of a Level Funded Healthcare Plan in T2DM
Favorite
13-296 - Pharmacoeconomic analysis of direct oral anticoagulants compared to warfarin in a managed care setting
Favorite
9-100 - The Impact of a Pharmacy-Based Transitions of Care Program on Heart Failure 30-Day Readmission Rates in a Community Hospital
Favorite
9-250 - The implementation of pharmacist-led medication therapy management program in Washington, DC Medicaid beneficiaries with hypertension
Favorite
9-381 - Use of a diabetes decision tree to evaluate the effectiveness of a pharmacist-run diabetes clinic on patient outcomes
Favorite
Clinical Services Management
11-151 - Analysis of a pharmacy resident-driven transitions of care service at a community teaching hospital
Favorite
12-148 - Analysis of current state transitions of care processes for heart failure patients at a community hospital and potential role of the pharmacist
Favorite
12-040 - Analysis of QTc Monitoring Best Practice Alert Integrated into an Electronic Health Record at a Large Academic Medical Center
Favorite
11-059 - Analysis of the efficacy of pneumococcal vaccine in a community pharmacy setting
Favorite
10-093 - Assessing outcomes of a newly initiated multidisciplinary culture-review process in the emergency department
Favorite
11-443 - Assessing patient satisfaction with comprehensive patient care services in a centralized specialty pharmacy
Favorite
13-195 - Assessing pharmacist discharge medication reviews on 30-day hospital readmission rates in patients discharged to skilled nursing facilities
Favorite
13-410 - Assessing the impact of a pharmacist led transitions of care team during hospital discharge
Favorite
9-156 - Assessment of clinical pharmacist productivity and return on investment after implementation of real-time clinical surveillance technology
Favorite
10-009 - Assessment of dedicated clinical pharmacist transitions of care services in a rural community hospital targeting patients with congestive heart failure
Favorite
13-277 - Assessment of pharmacist competency during cardiopulmonary arrest code participation in a community hospital
Favorite
10-254 - Assessment of pharmacist-led warfarin dosing versus non-pharmacist warfarin dosing in an Academic Medical Center
Favorite
11-160 - Assessment of pharmacy bundle services on hospital readmission of congestive heart failure (CHF) and acute myocardial infarction (AMI) patients
Favorite
11-250 - Clinical impact and patient perception of pharmacist initiated diabetes self-management education (DSME) in a community-based pharmacy setting
Favorite
12-023 - Confronting the opioid epidemic through implementation of a pharmacist driven emergency department education program on alternatives to opioids for painful conditions
Favorite
10-230 - Conversion to a central order processing model: impact on turnaround time, clinical outcomes, employee and patient satisfaction
Favorite
10-058 - Current utilization of clinical pharmacists in the emergency department at United States academic medical centers
Favorite
11-288 - Evaluating the impact of a pharmacy patient assistance coordinator at a community hospital
Favorite
12-422 - Evaluation of a diabetic ketoacidosis protocol at a rural community hospital
Favorite
12-200 - Evaluation of a specialty hepatitis C virus (HCV) pharmacy service
Favorite
11-441 - Evaluation of a specialty pharmacy technician-led adherence program
Favorite
13-311 - Evaluation of an alvimopan stewardship program
Favorite
11-398 - Evaluation of Clinical Pharmacist Services in Inflammatory Bowel Disease Management: A Patient-Centered-Care Model
Favorite
12-139 - Evaluation of pharmacist diabetes transition of care consults for intensive care unit patients
Favorite
13-146 - Evaluation of Pharmacy-led discharge counseling in patients at high risk of readmission
Favorite
10-055 - Evaluation of staff utilization of a pharmacy driven vancomycin dosing and therapeutic drug monitoring protocol at an academic medical center
Favorite
11-253 - Evaluation of targeted pharmacist education on HIV medication adherence rates
Favorite
12-036 - Evaluation of the predictive strength of a novel risk assessment tool in identifying patients at high risk of hospital readmission
Favorite
10-297 - Evaluation of transition of care pharmacy services
Favorite
11-142 - Evaluation of using a patient specific readmission risk score to target transitions of care services in a community hospital
Favorite
11-442 - Examination of a community pharmacy-based type 2 diabetes mellitus education and management program on changes in patient outcomes
Favorite
10-098 - Expanded pharmacist coverage in the emergency department: What value did we add and what are we still missing?
Favorite
12-253 - Expanding pharmacist discharge counseling in patients with heart failure: a process improvement initiative
Favorite
10-317 - Identification of specific patient populations to optimize the impact of pharmacist-led medication histories in a community hospital
Favorite
10-436 - Identifying Gaps and Pharmacist involvement in Transitioning of Care from Hospital to Home at Tertiary Hospitals in Jeddah, Saudi Arabia
Favorite
9-391 - Identifying strategies for adherence improvement and intervention implementation: an assessment of pharmacy team perceptions
Favorite
10-139 - Impact of a chronic obstructive pulmonary disease (COPD) exacerbation order set on hospital length of stay in a community hospital
Favorite
12-243 - Impact of a clinical pharmacist on a trauma/general surgery service at a level 1 trauma center
Favorite
11-328 - Impact of a pharmacist led Collaborative Practice Agreement for the management of chemotherapy induced nausea and vomiting (CINV) in a community oncology setting
Favorite
10-111 - Impact of a pharmacist-driven outpatient antimicrobial management service on hospital readmission rates and length of stay
Favorite
11-205 - Impact of a pharmacy-led Clostridium difficile infection therapy protocol in a community hospital
Favorite
11-271 - Impact of area under the concentration-time curve (AUC) based vancomycin drug monitoring approach on achievement of therapeutic goals
Favorite
13-219 - Impact of decentralized clinical pharmacists on the discharge of patients with high risk medications
Favorite
13-008 - Impact of educational interventions for providers on appropriate prescribing and monitoring of patients on long-term opioid pain management
Favorite
10-435 - Impact of implementation of insulin computerized order set for the control of hyperglycemia in hospitalized cardiac patients with type II diabetes mellitus
Favorite
12-336 - Impact of pharmacist consult and intervention on 30-day readmission rates for patients with a reduced ejection fraction less than or equal to 40 percent
Favorite
11-267 - Impact of pharmacist incorporation in a transdisciplinary transition of care team on 30-day readmission rates of high risk patients
Favorite
12-405 - Impact of pharmacist interventions and counseling at discharge on 30-day readmission rate for congestive heart failure patients in a rural healthcare setting
Favorite
9-423 - Impact of pharmacist-delivered inpatient medication counseling on 30-day readmission rates
Favorite
12-091 - Impact of pharmacist-facilitated interventions on 30-day heart failure readmission rates as part of a multi-disciplinary transitions-of-care program
Favorite
10-097 - Impact of pharmacist-led medication counseling on Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores
Favorite
12-406 - Impact of Procalcitonin Guided Antimicrobial Therapy Within a Rural Community Hospital
Favorite
13-267 - Impact of the layered learning practice model (LLPM) on IV to PO conversion assessments in an inpatient community hospital
Favorite
10-103 - Implementation and evaluation of a pharmacist driven medication reconciliation service in an academic medical center
Favorite
9-251 - Implementation of a community pharmacy-led transitions of care service on reducing 30-day readmission in patients with chronic obstructive pulmonary disease (COPD)
Favorite
11-312 - Implementation of a Medication Hotline to reduce post-discharge medication events
Favorite
9-188 - Implementation of a meds-to-beds and post discharge follow-up phone call service in a community hospital
Favorite
12-095 - Implementation of a Meds-to-Beds program for post-PCI patients on dual antiplatelet therapy
Favorite
12-304 - Implementation of a multi-dose medication dispensing for discharge (MMDD) program for asthma and chronic obstructive pulmonary disease (COPD) patients
Favorite
9-375 - Implementation of a pharmacist-managed transitions of care service in patients’ preferred language in a Spanish speaking community
Favorite
12-093 - Implementation of a respiratory therapy bronchodilator adjustment protocol based on patient-response
Favorite
13-264 - Implementation of a transitions of care pharmacist in an acute care community hospital
Favorite
10-263 - Implementation of pharmacogenomics dosing guidance for psychiatric medications beyond the current Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines
Favorite
11-381 - Implementing a collaboratively managed, pharmacist directed, hepatitis C treatment clinic
Favorite
11-107 - Implementing a pharmacist driven medication therapy management service at St. Luke’s Magic Valley
Favorite
10-262 - Implementing a pharmacy-driven therapy management program for ambulatory patients utilizing specialty pharmacy medications
Favorite
11-368 - Improving transitions of care: optimization of pharmacy-driven medication reconciliation services
Favorite
12-399 - Incidence and severity of hypoglycemia with a pharmacist-managed basal insulin protocol compared to usual care in a multi-hospital system
Favorite
9-065 - Increasing utilization and healthcare team involvement in a transitions of care meds-to-beds program
Favorite
12-360 - Initiation of an admission medication reconciliation service focused on high risk Congestive Heart Failure patients utilizing the systems approach in a community hospital
Favorite
12-401 - Inpatient glycemic control with a pharmacist-managed basal insulin protocol compared to usual care in a multi-hospital system
Favorite
11-373 - Interdisciplinary collaboration to expand and optimize current clinical services for behavioral health patients
Favorite
11-375 - Interdisciplinary rounding to reduce heart failure readmissions an improve goal-directed medication therapy
Favorite
10-307 - Intravenous Opioid Shortages: Assessing the Impacts of Pharmacy Interventions on Opioid Utilization and Patient Safety
Favorite
9-410 - Modification and reassessment of a pharmacy resident rotation integrated into a family medicine rounding service to enhance resident learning experiences
Favorite
13-421 - Multidisciplinary approach to improve alcohol withdrawal management in a community hospital setting
Favorite
10-244 - Ohio pharmacists knowledge and utilization of the patient care process
Favorite
11-359 - Optimizing communication and interventions in a pharmacist led transitions of care program
Favorite
11-037 - Perception of pharmacists’ prescriptive authority for smoking cessation medications among patients, prescribers, and pharmacists
Favorite
11-044 - Pharmacist initiated discharge counseling in high-risk patients
Favorite
11-403 - Pharmacist led management of acute postoperative pain for patients with total hip replacement
Favorite
9-420 - Pharmacist-led approach to minimize medications errors using medication reconciliation post-discharge and at follow-up
Favorite
9-213 - Provider response rates to different formats of medication refill requests for medicine on time (MOT) program participants
Favorite
12-366 - Real-time pharmacy monitoring for venous thromboembolism (VTE) prophylaxis in a community-hospital setting: Revitalization of the intervening process
Favorite
11-325 - Retrospective review of 30-day readmission rates of discharged patients to identify benefits of a discharge pharmacist
Favorite
9-192 - Vancomycin dosing service evaluation
Favorite
Clinical Topics/Therapeutics
13-108 - A comparison of albumin replacement with 4 g/L versus 8 g/L for large-volume paracentesis in cirrhotic patients
Favorite
11-095 - Addressing barriers to outpatient insulin adherence during transitions of care
Favorite
11-239 - Analysis of the etiologies and causative medications in hospital-acquired acute kidney injury
Favorite
13-184 - Assessing impact of a pharmacist-directed erythropoietin stimulating agent dosing protocol at an outpatient community hospital dialysis unit
Favorite
12-019 - Assessing the impact of a pharmacist-led in-service on appropriate antimicrobial utilization in a community hospital
Favorite
9-401 - Assessment of current prescribing practices of adult non-intensive care unit electrolyte replacement in a Midwest tertiary care hospital
Favorite
10-260 - Clinical outcomes in patients following a switch from the infliximab originator to a biosimilar product
Favorite
12-363 - Comparison of chlordiazepoxide and lorazepam in symptom-triggered regimens for alcohol withdrawal syndrome: a retrospective cross-site analysis
Favorite
10-133 - Comparison of continuous versus intermittent pantoprazole dosing in upper gastrointestinal bleeding: A retrospective cohort
Favorite
12-282 - Deprescribing chronic Proton Pump Inhibitor use to prevent long term adverse events
Favorite
11-345 - Developing a standard process for renal function assessment and medication dose adjustment
Favorite
13-052 - Diabetic ketoacidosis: a retrospective evaluation of time to resolution
Favorite
9-327 - Dosing and monitoring of vancomycin therapy using area-under the curve to minimum inhibitory concentration ratio vs. trough-based measurements
Favorite
10-246 - Effect of average inpatient blood glucose greater than 140mg/dL on patient outcomes
Favorite
11-307 - Effect of compliance of enhanced recovery after surgery (ERAS) protocols on pain control at a community medical center
Favorite
10-077 - Effect of enhanced recovery after surgery (ERAS) in colorectal patients in a large community hospital
Favorite
10-008 - Effectiveness of guideline assisted antibiotic therapy in patients diagnosed with an uncomplicated urinary tract infection (UTI) in an emergency department setting
Favorite
10-447 - Efficacy and Safety of Daclatasvir and Asunaprevir Combination Therapy in Elderly Chronic Hepatitis C Patients
Favorite
13-377 - Evaluating diabetic ketoacidosis protocol usage
Favorite
10-401 - Evaluating the effectiveness of multidisciplinary inhaler optimization on 30-day hospital readmissions for patients with chronic obstructive pulmonary disease
Favorite
12-362 - Evaluating the efficacy of gradual dose reduction (GDR) for reducing antipsychotic medication use in nursing home patients: a single center retrospective study
Favorite
10-181 - Evaluating the impact of GLP-1 agonists on metabolic changes in patients with type 2 diabetes and intensive insulin regimens
Favorite
13-352 - Evaluating the incidence and outcomes of hepatitis C through pharmacist-led screenings in an opioid-use disorder protocol program
Favorite
10-243 - Evaluating the potential role of statin therapy in the reduction of gentamicin-induced nephrotoxicity: A retrospective cohort study
Favorite
13-178 - Evaluating the use of anti-Xa levels to monitor enoxaparin in obese and morbidly obese patients in a community hospital setting
Favorite
13-162 - Evaluating the use of patiromer for management of hyperkalemia within a community hospital health-system
Favorite
10-333 - Evaluation of chronic obstructive pulmonary disease regimens upon discharge
Favorite
9-294 - Evaluation of clinical inertia and follow-up in patients with poorly controlled diabetes
Favorite
13-037 - Evaluation of diabetic ketoacidosis outcomes after implementation of a standardized diabetic ketoacidosis guideline at a five hospital health-system
Favorite
13-389 - Evaluation of epoetin use in chronic kidney disease at an academic medical center
Favorite
13-051 - Evaluation of outcomes associated with aspirin 81 mg twice daily for venous thromboembolism (VTE) prophylaxis in patients following total-knee arthroplasty (TKA) or total-hip arthroplasty (THA)
Favorite
9-154 - Evaluation of pharmacist intervention on length of therapy and appropriate use of stress ulcer prophylaxis
Favorite
9-211 - Evaluation of risk factors for development of hypoglycemia in patients with diabetic ketoacidosis while on a continuous intravenous insulin infusion
Favorite
11-134 - Evaluation of selective serotonin reuptake inhibitors and their impact on the incidence and severity of intracranial and gastrointestinal bleeding
Favorite
9-390 - Evaluation of the impact of accurately administered antibiotics on length of hospital stay
Favorite
10-250 - Evaluation of the safety and efficacy of metformin use in hospitalized, non-critically ill patients
Favorite
12-258 - Evaluation of Vitamin K Usage during Pulmonary Exacerbation in Adult Cystic Fibrosis
Favorite
10-450 - Evidence-based Deprescribing of Proton Pump Inhibitors: Outcomes of an Interdisciplinary Approach in a Tertiary Care Center in the UAE
Favorite
12-307 - Impact of a pharmacist driven insulin dosing protocol on the incidence of hypoglycemic events
Favorite
11-445 - Implementation of a pharmacy dosing consult for insulin glargine in an acute care community hospital
Favorite
13-072 - Implementation of an enhanced recovery after surgery (ERAS) protocol in bariatric surgical patients to decrease post-operative nausea and vomiting: a retrospective chart review
Favorite
12-082 - Implementing pharmacist driven glycemic control to evaluate patient days within target range and malglycemia
Favorite
10-418 - Incidence of hypoglycemia in the setting of acute kidney injury in general medicine patients receiving basal insulin
Favorite
11-276 - Intrapleural alteplase (tPA) and dornase alfa for the treatment of pleural effusions and empyema
Favorite
9-354 - Length of stay (LOS) evaluation in patients treated with lactulose vs. lactulose plus rifaximin for the initial treatment of overt hepatic encephalopathy (HE)
Favorite
12-310 - Management of tolvaptan using an evidence-based order set and its role in improving safe tolvaptan use
Favorite
13-128 - NO-COPS: naloxone and opiate co-prescribing strategies in a family medicine residency program
Favorite
13-304 - Outcomes of pharmacy based program to decrease use of sulfonylureas in hospitalized patients
Favorite
12-220 - Pharmacist driven intervention using spironolactone in heart failure with preserved ejection fraction
Favorite
12-385 - Potential role of community pharmacists in identifying gaps in cardiovascular disease risk management and vaccine recommendations in patients with diabetes
Favorite
13-249 - Prescribing patterns of multiple chronic medications that can prolong the QT interval in an indigent population in South Florida
Favorite
9-229 - Rectal Indomethacin for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients
Favorite
9-414 - Retrospective review of insulin dose reduction required on hospital admission
Favorite
10-378 - Review of as needed antihypertensive use in the hospital setting
Favorite
9-042 - Safety and efficacy of intravenous insulin aspart for the treatment of hyperkalemia: preliminary results
Favorite
11-279 - Standard versus high-dose enoxaparin for venous thromboembolism prophylaxis in morbidly obese patients
Favorite
Complementary Alternative Medicine (Herbals, etc.)
12-100 - Effect of topical diltiazem gel at 2 percent on management of levator ani syndrome
Favorite
13-370 - Evaluation concerning testing utilization, prescription medications, and over the counter supplements following a diagnosis of Alzheimer’s disease
Favorite
Critical Care
9-235 - 23.4 Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure
Favorite
10-223 - A retrospective evaluation of midodrine as a vasopressor-weaning agent in cardiovascular intensive care unit patients
Favorite
11-425 - A single centre randomized controlled trial to evaluate dronabinol for acute pain management in adults with traumatic injury
Favorite
11-408 - Adherence to analgesia-first sedation in the adult intensive care unit (ICU)
Favorite
13-174 - Analysis of dose differences of quetiapine in the management of delirium in the intensive care unit
Favorite
12-349 - Anti-factor Xa Monitoring of Unfractionated Heparin in Patients on Extracorporeal Membrane Oxygenation (ECMO)
Favorite
12-179 - Antimicrobial use in cardiac surgery patients with delayed sternal closure
Favorite
11-073 - Assessing a diabetic ketoacidosis order set to improve safety and clinical outcomes within an integrated health system
Favorite
13-337 - Assessing outcomes in congestive heart failure patients presenting with septic shock receiving standard versus reduced initial fluid resuscitation volume
Favorite
13-335 - Assessing the effectiveness of modafinil as an adjunctive therapy to assist in the weaning of mechanical ventilation
Favorite
9-061 - Assessing the use of procalcitonin in critically-ill patients with sepsis or septic shock
Favorite
12-218 - Assessment and efficacy of current alcohol withdrawal syndrome protocol
Favorite
9-257 - Assessment of dyskalemia with pentobarbital administration using a monitoring protocol
Favorite
12-332 - Assessment of intravenous ascorbic acid, thiamine, and corticosteroids for the treatment of sepsis in a 351 bed community teaching hospital
Favorite
10-015 - Assessment of intravenous sodium bicarbonate use in critically-ill patients with an acute kidney injury for the treatment of acidosis
Favorite
12-123 - Assessment of vancomycin dosing in critically ill patients on continuous renal replacement therapy
Favorite
12-135 - Augmented renal clearance in the surgical intensive care unit
Favorite
10-200 - Barriers to Sepsis Fluid Resuscitation Compliance: Evaluating High-Risk Patients and Fluid Resuscitation Strategies
Favorite
13-226 - Benzodiazepine-sparing protocol for the management of alcohol withdrawal syndrome in the critically ill
Favorite
9-016 - Can implementation of a strict protocol for the use of angiotensin II result in better efficacy outcomes in vasodilatory shock?
Favorite
9-052 - Categorizing Administration Practices for Vasopressors at Community Medical Centers
Favorite
10-267 - Characteristics of neostigmine use for ileus in trauma intensive care unit patients
Favorite
9-301 - Clinical Efficacy of Adjunctive Dexmedetomidine Use in the Treatment of Alcohol Withdrawal as Compared to Symptom-Triggered Therapy in Critically Ill Patients
Favorite
13-093 - Clinical Impact of an Enteral Opiate Optimization Program in the Adult MICU Setting (COELOM)
Favorite
11-275 - Clinical outcomes associated with the use of phenobarbital in patients with alcohol withdrawal syndrome
Favorite
9-036 - Clinical outcomes of patients requiring reversal of acute major bleeds caused by rivaroxaban or apixaban
Favorite
13-280 - Clinical pharmacist integration into the rapid response team at a community hospital
Favorite
13-103 - Code sepsis rapid response: implementation of a pharmacist and nurse driven protocol
Favorite
10-096 - Comparing the choice of second vasopressor in septic shock refractory to norepinephrine
Favorite
13-261 - Comparison of a multimodal stepwise shivering management strategy to a neuromuscular blocker-first strategy for targeted temperature management after cardiac arrest
Favorite
10-329 - Comparison of alpha-2a agonists as adjunctive therapy for alcohol withdrawal syndrome
Favorite
10-364 - Comparison of continuous infusion versus bolus hypertonic saline administration for inducing hypernatremia in the treatment of cerebral edema
Favorite
12-313 - Comparison of electrolyte abnormalities when a phosphate containing versus a non-phosphate containing renal replacement solution is utilized: a retrospective cohort study
Favorite
12-013 - Comparison of high-dose versus standard-dose levetiracetam maintenance therapy in adult patients with status epilepticus
Favorite
12-178 - Comparison of intravenous milrinone therapy versus standard hemodynamic augmentation on the severity and duration of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH)
Favorite
11-258 - Comparison of midazolam and propofol sedation strategies in survivors of cardiac arrest during targeted temperature management
Favorite
9-303 - Comparison of the adjunctive use of ketamine versus standard of care in sedation and analgesic management in patients receiving veno-venous extracorporeal membrane oxygenation
Favorite
12-414 - Comparison of time to shock reversal with hydrocortisone 200 mg/day versus hydrocortisone 300 mg/day in intensive care unit (ICU) patients with septic shock
Favorite
13-338 - Comparison of vasopressor requirements in mechanically ventilated patients sedated with dexmedetomidine versus propofol
Favorite
13-218 - Correlation of lipophilic and hydrophilic statins to major bleeding events
Favorite
10-078 - Cost comparison and utilization of activated prothrombin complex concentrate (aPCC) for anticoagulant-related bleeding
Favorite
11-269 - Cost effectiveness of argatroban versus heparin anticoagulation in adult extracorporeal membrane oxygenation patients
Favorite
10-150 - Delays in administration of the second antibiotic dose in severe sepsis and septic shock
Favorite
9-438 - Description of bivalirudin anticoagulation in pediatric patients with ventricular assist devices
Favorite
12-168 - Design and implementation of a hospital guideline for the management of calcium channel blocker and beta blocker toxicity
Favorite
11-385 - Development and implementation of a multidisciplinary education plan for delirium in the intensive care unit
Favorite
10-010 - Development of a medication therapy management scoring index in critically ill patients at a community hospital
Favorite
11-363 - Development of a standardized protocol for the use of intravenous vitamin C, thiamine, and hydrocortisone in the treatment of sepsis and septic shock
Favorite
10-013 - Development of an algorithm for clinical decision making regarding intravenous loop diuretics in patients with acute decompensated heart failure
Favorite
9-270 - Diabetic ketoacidosis management: a comparison of a two-bag versus a one-bag system in adult patients
Favorite
12-182 - Diuretic response to furosemide plus albumin vs furosemide alone in surgical intensive care unit patients
Favorite
11-281 - Drug utilization evaluation comparing the incidence of acute kidney injury in critically ill patients receiving vancomycin and piperacillin/tazobactam versus vancomycin and cefepime or meropenem
Favorite
10-027 - Effect of a pharmacist-driven medication review on delirium in critically ill patients
Favorite
11-329 - Effect of adjunct midodrine on length of stay in vasopressor-dependent adult ICU patients
Favorite
13-398 - Effect of Amitriptyline on Delirium in Trauma Intensive Care Unit (ICU) Patients
Favorite
13-107 - Effect of cefepime dosage on adverse effects in critically ill adult patients
Favorite
11-211 - Effect of oral midodrine on duration of intravenous vasopressor therapy and hospital length of stay
Favorite
13-312 - Effectiveness of adjunctive midodrine therapy for decreasing duration of norepinephrine use in patients admitted to the intensive care unit
Favorite
13-306 - Effectiveness of protocol for decreasing utilization of pantoprazole in the intensive care unit to avoid unnecessary continuation upon discharge
Favorite
12-196 - Efficacy and Safety of Push Dose Phenylephrine in Adult ICU Patients
Favorite
13-054 - Efficacy of a nurse driven diabetic ketoacidosis protocol on diabetic ketoacidosis treatment and serum osmolarity
Favorite
10-043 - Efficacy of melatonin for the prevention of intensive care unit (ICU) delirium
Favorite
11-003 - Efficacy of midodrine to decrease intravenous vasopressor requirements in ICU patients
Favorite
13-061 - Efficacy of using antipsychotics as adjunct therapy to benzodiazepines in severe alcohol withdrawal
Favorite
13-326 - Enteral naloxone for opioid-induced constipation: a single pediatric intensive care unit experience
Favorite
13-257 - Enteral nutrition in critically ill patients with concurrent vasopressors: is it safe
Favorite
13-244 - Evaluating adherence to an institutional insulin infusion protocol for critical care patients in a community healthcare system
Favorite
9-304 - Evaluating the management of patients recovering from septic shock: a retrospective before and after shock protocol study
Favorite
12-280 - Evaluating the use of phenobarbital for treatment of severe alcohol withdrawal syndrome in the medical intensive care unit
Favorite
11-347 - Evaluation and Optimization of an Alcohol Withdrawal Protocol
Favorite
13-189 - Evaluation of 4-Factor Prothrombin Complex Concentrate (4F-PCC) for reversal of warfarin in a tertiary care hospital
Favorite
11-125 - Evaluation of 4-factor prothrombin complex concentrate in an era of expanding use
Favorite
9-015 - Evaluation of a pharmacist driven CAM-ICU assessment protocol
Favorite
12-395 - Evaluation of a standardized vancomycin administration time protocol on vancomycin levels in medical intensive care unit patients in an academic medical center
Favorite
12-065 - Evaluation of adherence to daily spontaneous awakening trials (SATs) and spontaneous breathing trials (SBTs) and effect on clinical outcomes: a before-, during-, and after-education study
Favorite
13-288 - Evaluation of aerosolized epoprostenol sodium utilization in the intensive care unit
Favorite
13-416 - Evaluation of albumin use in a 48 bed adult intensive care unit
Favorite
9-099 - Evaluation of alcohol withdrawal management and prescribing practices in the trauma-neuro critical care and medical intensive care units
Favorite
10-419 - Evaluation of Alteplase Regimen and Outcomes in the Treatment of Pulmonary Embolism
Favorite
10-336 - Evaluation of an insulin infusion protocol for glycemic control at an academic medical center
Favorite
11-296 - Evaluation of antipsychotic continuation for intensive care unit (ICU) delirium management through transitions of care
Favorite
13-242 - Evaluation of antipsychotic therapy for intensive care unit (ICU) delirium
Favorite
10-361 - Evaluation of antipsychotics known to cause QTc prolongation in adult intensive care unit patients
Favorite
11-158 - Evaluation of appropriate analgesia and sedation prior to neuromuscular blocking agent initiated in critically ill patients
Favorite
9-073 - Evaluation of current practices for fentanyl drip titration in ventilated patients admitted to the medical intensive care unit
Favorite
13-111 - Evaluation of dexmedetomidine use and appropriateness in adult patients admitted to an intensive care unit
Favorite
10-031 - Evaluation of early administration of insulin glargine in the acute management of diabetic ketoacidosis
Favorite
13-047 - Evaluation of efficacy of hypertonic saline and mannitol in combination in patients with a traumatic brain injury
Favorite
11-026 - Evaluation of factors contributing to prolonged intubation times in patients undergoing cardiovascular surgery
Favorite
11-410 - Evaluation of fluid resuscitation in sepsis
Favorite
11-064 - Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Neurocritical Care Unit
Favorite
11-156 - Evaluation of insulin infusions in critically ill patients
Favorite
10-360 - Evaluation of ketamine for sedation in the intensive care unit (ICU)
Favorite
10-443 - Evaluation of medication discrepancies upon discharge from intensive care units at an academic medical center in Riyadh, Saudi Arabia
Favorite
11-009 - Evaluation of medications used as part of a rapid response team without a pharmacist in a rural health center
Favorite
11-119 - Evaluation of midazolam utilization and dosing strategy for refractory status epilepticus
Favorite
13-005 - Evaluation of midodrine use for septic shock in the medical intensive care unit (ICU)
Favorite
9-209 - Evaluation of pain control in patients with thermal injury
Favorite
11-155 - Evaluation of phentolamine and hyaluronidase use following extravasation of vasopressors
Favorite
9-350 - Evaluation of Prescribing Patterns of Quetiapine for Delirium in Critically Ill Patients
Favorite
9-098 - Evaluation of prescribing practices of hyperosmolar therapy in adult patients with traumatic brain injury
Favorite
10-239 - Evaluation of prophylactic antibiotics in penetrating brain injuries at an academic Level 1 Trauma Center
Favorite
9-145 - Evaluation of protocol based, symptom triggered phenobarbital treatment for alcohol withdrawal syndrome in critically ill patients
Favorite
13-185 - Evaluation of safety and efficacy of rapid-titration treprostinil at a large community hospital
Favorite
10-040 - Evaluation of Single versus Serial Procalcitonin Lab Monitoring in Critically Ill Patients
Favorite
12-140 - Evaluation of systemic corticosteroid use in septic shock patients across a multi-hospital health system
Favorite
9-131 - Evaluation of the appropriateness of prophylactic antibiotics in patients with external ventricular drains
Favorite
13-212 - Evaluation of the duration of epilepsy prophylaxis in aneurysmal subarachnoid hemorrhage
Favorite
9-035 - Evaluation of the effect of intravenous acetaminophen on defervescense in critically ill patients
Favorite
9-387 - Evaluation of the Effects of Midodrine on Vasopressor Weaning in the Intensive Care Units
Favorite
11-133 - Evaluation of the safety and efficacy of phenobarbital for the management of acute alcohol withdrawal in the intensive care unit
Favorite
11-056 - Evaluation of the use of oral midodrine to wean vasopressors in critically ill patients diagnosed with shock
Favorite
11-409 - Evaluation of utilization of a continuous insulin infusion program in critically-ill patients
Favorite
9-371 - Evaluation of vasopressin response in critically ill patients on chronic ACE-inhibitor therapy
Favorite
11-154 - Evaluation of vasopressin usage in critical care patients
Favorite
13-076 - Evaluation of vasopressor discontinuation sequence on hemodynamic stability in septic shock
Favorite
12-074 - Fentanyl versus hydromorphone infusion for pain and sedation in mechanically ventilated patients in the intensive care unit
Favorite
12-064 - Fixed Dose Kcentra Protocol for Emergent Warfarin Reversal
Favorite
9-360 - Fixed dose prothrombin complex concentrate versus variable dosing for the emergent reversal of warfarin in a community hospital
Favorite
13-068 - Heparin dosing in ECMO patients
Favorite
9-231 - Hydrocortisone and Fludrocortisone versus Hydrocortisone Alone in Critically Ill Medical Patients with Septic Shock
Favorite
9-227 - Identifying risk factors for ventilator associated pneumonia due to Pseudomonas aeruginosa in a trauma population
Favorite
10-189 - Impact of a pharmacist- managed quality improvement initiative on the appropriateness of stress ulcer prophylaxis in critically ill adults
Favorite
13-100 - Impact of a pharmacist-driven sliding scale insulin protocol on glycemic control in a critical care setting
Favorite
10-054 - Impact of a standardized trauma admission order set on time to venous thromboembolism prophylaxis in a level I trauma center
Favorite
9-252 - Impact of an electronic sepsis surveillance tool on early sepsis management in the emergency department
Favorite
9-271 - Impact of changing from weight-based to standard dosing of continuous intravenous fentanyl infusion on overall fentanyl utilization in a medical-surgical intensive care unit
Favorite
11-195 - Impact of Chloride Containing Drug Diluents on AKI Incidence in the Surgical Intensive Care Unit
Favorite
10-193 - Impact of continuous vasopressin infusion in patients diagnosed with shock
Favorite
11-417 - Impact of daily patient medication reviews in the intensive care unit (ICU)
Favorite
13-016 - Impact of dexmedetomidine use on hospital length of stay and benzodiazepine requirements in patients being treated for alcohol withdrawal
Favorite
13-271 - Impact of enteral clonidine on the duration of dexmedetomidine infusions in intensive care unit patients
Favorite
13-315 - Impact of high-dose intravenous vitamin C for treatment of sepsis on point-of-care blood glucose readings
Favorite
11-248 - Impact of intravenous N-acetylcysteine in non-acetaminophen acute liver failure in the intensive care unit
Favorite
13-273 - Impact of moderate hyperchloremia on trauma patients treated with continuous infusion hypertonic saline
Favorite
11-101 - Impact of pharmacist-led interventions on stress ulcer prophylaxis and atypical antipsychotic use upon discharge from the intensive care unit
Favorite
12-249 - Impact of pharmacy intervention on inappropriate use of stress ulcer prophylaxis in the intensive care unit (ICU)
Favorite
11-259 - Impact of phenobarbital in the management of alcohol withdrawal syndrome on outcomes in critically ill adults
Favorite
10-433 - Impact of procalcitonin on duration of antibiotic therapy in adults with sepsis or septic shock in the intensive care unit
Favorite
11-210 - Impact of prolonged postoperative dexmedetomidine infusions on analgesic requirements in pediatric patients
Favorite
13-165 - Impact of protocolized sleep improvement with early mobilization utilizing fitness watch technology in the intensive care unit
Favorite
12-133 - Impact of steroids in septic shock requiring low dose norepinephrine
Favorite
13-168 - Implementation of clinical pharmacy services to assess patients with intensive care unit delirium
Favorite
9-282 - Implementation of ICU bundles and the impact on pain, agitation, and delirium in critically ill patients in the ICU
Favorite
9-088 - Implementation of pharmacy services into an emergency department
Favorite
11-072 - Improving adherence to a standardized ventilator order set: a quality improvement project
Favorite
11-127 - Improving glycemic control in critically ill patients by use of a computerized dosing support system in a community hospital setting
Favorite
9-030 - Improving the process of alteplase management for inpatient acute ischemic stroke
Favorite
10-402 - Incidence and risk factors for multidrug resistant infection in trauma patients admitted with penetrating abdominal injuries
Favorite
12-265 - Incidence of acute kidney injury in septic patients receiving normal saline or balanced fluids
Favorite
11-306 - Incidence of antibiotic administration before lumbar puncture and CSF gram stain in critically ill patients with suspected bacterial meningitis and the effect on patient outcomes
Favorite
12-177 - Incidence of fever associated with dexmedetomidine in an adult intensive care unit
Favorite
9-242 - Individualized versus fixed schedule benzodiazepine therapy for alcohol withdrawal: a comparison of treatment strategies at a university-affiliated acute care teaching hospital
Favorite
11-070 - Initiation of Pharmacy Consult Services to Improve Sepsis Related Outcomes in a Multi-Hospital Health System
Favorite
13-366 - Insulin infusion protocol for acute hyperglycemic crisis: assessing compliance, safety, and efficacy in an academic medical center
Favorite
10-403 - Interventions for hyperglycemia in the medical and surgical intensive care unit
Favorite
12-203 - Intrapulmonary shunting secondary to intravenous nicardipine in post-operative cardiac surgery patients: a retrospective study
Favorite
12-076 - Intravenous Lidocaine Infusion for Management of Chronic Pain in the ICU
Favorite
13-256 - Ketamine for analgosedation in mechanically ventilated patients
Favorite
11-286 - Managing agitation and sedation in the critically ill: intravenous dexmedetomidine to oral clonidine
Favorite
12-257 - Medication Use Evaluation of 4-Factor Prothrombin Complex (Kcentra®) at an Urban Academic Medical Center
Favorite
13-381 - Medication use evaluation of methylene blue
Favorite
12-351 - Medication use evaluation of milrinone for the treatment of cerebral vasospasm associated with subarachnoid hemorrhage
Favorite
11-116 - Medication use evaluation of vasopressin and incidence of hypotension in a critical care setting
Favorite
13-172 - Medication use evaluation: albumin use post-cardiothoracic surgery
Favorite
10-151 - Midodrine for adjunctive support in the weaning of vasopressor infusions in the intensive care unit
Favorite
9-094 - Modafinil for wakefulness in the neurocritical care unit
Favorite
11-212 - Opioid shortage: impact on critically ill patients
Favorite
12-104 - Opportunities for the transition from dexmedetomidine to enteral clonidine
Favorite
12-185 - Optimal timing of venous thromboembolism (VTE) prophylaxis initiation in all trauma patients
Favorite
13-367 - Outcomes of a vasopressin continuous infusion protocol in patients with central diabetes insipidus
Favorite
12-169 - Outcomes of activated prothrombin complex concentrate in patients using factor-Xa inhibitors and experiencing acute major bleeding
Favorite
11-324 - Patient outcomes in an adult intensive care unit (ICU) based on depth of sedation while intubated; a retrospective chart review
Favorite
10-266 - Pharmacist led stress ulcer prophylaxis management in the intensive care unit
Favorite
11-240 - Pharmacy Facilitated Education of Appropriate Procalcitonin Assays and Physician Response
Favorite
12-361 - Phenobarbital compared to lorazepam in the treatment of alcohol withdrawal in a community hospital
Favorite
10-331 - Pilot Analysis of Outcomes Between Monitored Anesthesia Care With Dexmedetomidine and General Anesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement
Favorite
11-057 - Predicting patient response to dexmedetomidine in mechanically ventilated intensive care unit patients
Favorite
11-166 - Reduced dose alteplase in the treatment of acute pulmonary embolism
Favorite
10-271 - Retrospective analysis of pharmacist impact on advanced cardiovascular life support guideline adherence and outcomes during in-hospital cardiac arrest
Favorite
12-212 - Retrospective analysis of the safety and efficacy of angiotensin II in the treatment of vasodilatory shock within an urban teaching hospital
Favorite
13-408 - Retrospective study on the use of hydrocortisone plus fludrocortisone in adults with septic shock
Favorite
12-041 - Rifaximin for the treatment of septic shock in cirrhotic patients
Favorite
12-225 - Role of single versus dual antiepileptic drug prophylaxis after traumatic brain injury and spontaneous intracerebral hemorrhage
Favorite
13-283 - Safety and efficacy of hyperosmolar therapy in elevated intracranial pressure
Favorite
12-116 - Safety of high dose dexmedetomidine in adult intensive care unit patients
Favorite
11-015 - Safety of ketamine and propofol when used for sedation in mechanical ventilation in a trauma ICU
Favorite
10-042 - Steroid dosing for chronic obstructive pulmonary disease (COPD) exacerbations in the critically ill
Favorite
10-197 - Steroid dosing in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in criticially ill adults
Favorite
12-251 - Target Richmond agitation-sedation score (RASS) achievement with implementation of a multi-component order set for sedation in the intensive care unit
Favorite
11-406 - Targeted temperature management and patient outcomes after cardiac arrest
Favorite
11-030 - The opioid sparing effects of ketamine in an adult ICU population
Favorite
12-372 - The use of propofol plus dexmedetomidine in patients experiencing severe alcohol withdrawal in the intensive care unit
Favorite
12-295 - The use of vitamin C, hydrocortisone, and thiamine in patients diagnosed with septic shock
Favorite
10-169 - Treatment bundle of intravenous ascorbic acid, thiamine, and hydrocortisone for patients with sepsis in the intensive care unit
Favorite
10-198 - Treatment of acute hepatic encephalopathy in the intensive care
Favorite
10-202 - Treatment of acute hepatic encephalopathy in the intensive care
Favorite
10-417 - Use of adjunctive ketamine in resistant alcohol withdrawal: impact on symptom severity
Favorite
12-077 - Use of guanfacine for sedation and agitation in the intensive care unit
Favorite
11-021 - Utilization of 4-factor prothrombin complex concentrate for reversal of oral factor Xa inhibitor associated acute major bleeding: a case series
Favorite
10-407 - Utilization of nebulized medications for inhalational lung injury in burn patients
Favorite
11-159 - Utilization trends of albumin five percent at a community teaching hospital
Favorite
11-387 - Utilizing a clonidine protocol to assist the weaning of dexmedetomidine infusions
Favorite
11-420 - Vasopressor utilization in septic shock: an evaluation of initiation and weaning of vasoactive agents at Regional Health Rapid City Hospital
Favorite
12-379 - Which vasopressor should be stopped first? An accountable care organization multicenter study in septic shock patients with dual vasopressor therapy
Favorite
11-083 - Y-site compatibility of intravenous levetiracetam with commonly used critical care medications
Favorite
Drug Information/Drug Use Evaluation
9-431 - 4-Factor prothrombin complex concentrate (4FPCC) dosing strategies: a retrospective evaluation
Favorite
13-159 - A Medication Utilization Evaluation for the Appropriateness of Use of Intravenous Chlorothiazide
Favorite
12-227 - Analysis following implementation of an updated substitution protocol for inhaled medications
Favorite
13-323 - Analysis of Converting Insulin Detemir to Insulin Glargine: A Medication Use Evaluation
Favorite
12-259 - Analysis of hypoglycemic events in an inpatient setting: a medication use evaluation
Favorite
11-447 - Antibiotic prescribing during transitions of care for hospitalized patients diagnosed with pneumonia
Favorite
12-373 - Antiemetic patterns of use and outcomes in a community teaching hospital
Favorite
12-308 - Appropriate use of 4-factor prothrombin complex concentrate: a retrospective study
Favorite
9-220 - Appropriate use of albumin at a tertiary care facility: A medication utilization evaluation
Favorite
13-392 - Appropriate use of epoetin alfa in the treatment of anemia in hemodialysis and continuous renal replacement therapy patients admitted to a community acute care hospital
Favorite
10-383 - Appropriate Use of Heparin-Induced Thrombocytopenia Lab Panels
Favorite
10-121 - Appropriateness of international classification of diseases (ICD-10) codes and prescribing practices of acute opioid prescriptions upon discharge
Favorite
12-309 - Appropriateness of proton pump inhibitors: a retrospective study
Favorite
9-338 - Appropriateness of Rabies Vaccine and Immune Globulin Utilization in the Emergency Department
Favorite
12-393 - Assessing appropriate de-escalation of antibiotics in urinary tract infections in academic medical centers
Favorite
9-404 - Assessing dispensing status of naloxone prescriptions from a pain clinic
Favorite
10-204 - Assessing inappropriate oral dosage form selection and administration of cardiac medications in patients with an enteral feeding tube in an intensive care unit (ICU)
Favorite
10-382 - Assessing the clinical appropriateness and associated drug costs of prescribing lansoprazole orally disintegrating tablets
Favorite
12-359 - Assessing the impact of an informational naloxone card on the number of naloxone prescriptions dispensed at community pharmacies located within a health center
Favorite
9-048 - Assessing the implementation of guideline-directed sacubitril-valsartan therapy in heart failure
Favorite
9-419 - Assessing vancomycin utilization, clinical appropriateness and safety in a community hospital
Favorite
10-242 - Assessment of calcitonin use at a tertiary medical center
Favorite
9-206 - Assessment of implementation of a single insulin infusion protocol in a burn center
Favorite
9-111 - Being smart about our antiretroviral therapy (ART)
Favorite
13-026 - Botulinum toxin usage evaluation and potential cost savings across a five hospital health-system
Favorite
10-355 - Buprenorphine use within acute care hospitals: A medication use evaluation
Favorite
12-005 - Ciprofloxacin-dexamethasone otic suspension utilization evaluation to identify potential cost savings at a children’s hospital
Favorite
9-344 - Clinical assessment of sub-therapeutic and supra-therapeutic vancomycin levels as a result of a pharmacy dosing and monitoring protocol
Favorite
11-237 - Clot in the nick of time: a medication use evaluation of enoxaparin treatment dosing in a multi-site pediatric hospital
Favorite
9-287 - Comparison of intermittent versus continuous infusion of intravenous pantoprazole in the treatment of upper gastrointestinal bleeds
Favorite
13-122 - Comparison of quality and usability of freely available guideline-focused websites following the shutdown of the National Guideline Clearinghouse
Favorite
9-003 - Comparison of the effects of intravenous and oral tranexamic acid (TXA) on perioperative hemoglobin levels during total knee arthroplasty
Favorite
13-163 - Compliance and outcome evaluation of hospital-formulated protocol on management of hyperkalemia
Favorite
11-197 - Compliance with and impact of ciprofloxacin criteria restriction at a tertiary academic medical center
Favorite
13-038 - Comprehensive review of intravenous (IV) cleanroom consumables across a five hospital health system
Favorite
12-387 - Cost savings and adherence assessment of an intravenous levothyroxine conservation protocol: One year later
Favorite
13-041 - Cost savings with erythropoietin stimulating agents in an academic medical center: standardizing weekly dosing days or switching to a biosimilar
Favorite
12-050 - Cost-effectiveness evaluation of pharmacist-led conversion from metered-dose inhalers to hand-held nebulizers in a non-teaching community medical center
Favorite
10-003 - Dinoprostone and misoprostol use evaluation across a national health system
Favorite
11-184 - Discharge opioid prescribing practices
Favorite
12-392 - Discontinuation of Proton Pump Inhibitors After Treatment of Clostridium Difficile Infection (DC PPI CDI)
Favorite
11-282 - Drug use evaluation of methylnaltrexone
Favorite
9-075 - Drug use evaluation of sliding scale insulin therapy in patients with type 2 diabetes mellitus (T2DM) in a community hospital
Favorite
13-342 - Drug utilization and cost management study of dinoprostone vaginal insert for cervical ripening
Favorite
11-039 - Drug utilization evaluation of injectable calcitonin for the treatment of hypercalcemia
Favorite
9-180 - Drug-use evaluation of clotting factor concentrates at a pediatric hospital
Favorite
9-349 - Drug-use evaluation of intravenous immunoglobulin (IVIG) weight-based dosing
Favorite
9-373 - Effect of a pharmacist-driven management protocol on the probiotic combination of Lactobacillus strains for prevention of Clostridium difficile infection (CDI) in hospitalized adult patients
Favorite
11-187 - Effect of Implementation of an eGlycemic Management System® on Time to Target Blood Glucose Range in a Community Hospital System
Favorite
13-409 - Effect of methicillin-resistant Staphylococcus aureus nares culture in suspected pneumonia on antimicrobial stewardship
Favorite
13-147 - Effects of liposomal bupivacaine vs. conventional bupivacaine on opioid use for post-surgical pain control following shoulder arthroplasty: a retrospective chart review
Favorite
11-178 - Efficacy and safety of lacosamide in seizure prophylaxis after traumatic brain injury
Favorite
11-041 - Empiric antibiotic guideline compliance in an observation unit
Favorite
11-452 - Empiric use of methylnaltrexone in postoperative orthopedic patients
Favorite
13-140 - Evaluating a formulary substitution of inhaled fluticasone to nebulized budesonide
Favorite
10-374 - Evaluating appropriateness of albumin use at a small community hospital
Favorite
11-245 - Evaluating appropriateness of anti-Xa level monitoring in patients receiving enoxaparin
Favorite
9-225 - Evaluating appropriateness of epoetin alfa prescribing at a community hospital
Favorite
10-334 - Evaluating Prescribing Practices of Intravenous Iron Therapy in Non-Hemodialysis Patients
Favorite
9-339 - Evaluating the Appropriate Use of Tdap Vaccine in the Emergency Department
Favorite
9-259 - Evaluating the efficacy of Exparel at providing postoperative analgesia in patients undergoing cholecystectomy
Favorite
13-066 - Evaluating the impact of an intravenous opioid restriction in response to national shortages
Favorite
10-376 - Evaluating the use and monitoring of lithium in a small community hospital
Favorite
12-358 - Evaluating the use of calcitonin at a tertiary academic medical center
Favorite
9-285 - Evaluating the use of Fidaxomicin for Clostridium difficile infections (CDI) at a large tertiary hospital
Favorite
12-303 - Evaluating the use of fludrocortisone in patients with acute hyperkalemia
Favorite
9-311 - Evaluating the use of liposomal bupivacaine post-surgery at a large academic medical center
Favorite
10-201 - Evaluating the use of published value frameworks in oncology formulary decisions at a non-profit, multi-hospital health-system
Favorite
10-449 - Evaluating the use of stress ulcer prophylaxis in a tertiary care hospital in the United Arab Emirates
Favorite
13-330 - Evaluating the use of systemic fluoroquinolones in a community hospital
Favorite
10-349 - Evaluating time to administration of cefepime intravenous push (IVP) versus cefepime intravenous piggyback (IVPB) in a medical/surgical intensive care unit (ICU)
Favorite
11-365 - Evaluation and implementation of a treatment algorithm for use of rescue therapies in adult and pediatric oncology
Favorite
9-064 - Evaluation of 4-factor prothrombin complex concentrate use in a large community hospital
Favorite
11-283 - Evaluation of a 48 hour sliding scale insulin (SSI) restriction on inpatient blood glucose control
Favorite
11-193 - Evaluation of a pharmacist-driven acute coronary syndrome heparin dosing protocol
Favorite
11-191 - Evaluation of a pharmacist-driven vancomycin pharmacokinetic dosing nomogram
Favorite
13-387 - Evaluation of a rapid bevacizumab protocol
Favorite
9-173 - Evaluation of accuracy and effective use of fosfomycin
Favorite
13-056 - Evaluation of acid suppressive therapy (AST) appropriateness in adult non-critically ill patients
Favorite
13-386 - Evaluation of acyclovir use and herpes simplex virus testing in patients receiving intravenous acyclovir
Favorite
10-210 - Evaluation of adherence to institutional guidelines for oral anticoagulant reversal management at a large, tertiary-care hospital
Favorite
13-060 - Evaluation of adherence to titratable continuous analgesia and sedation orders
Favorite
13-078 - Evaluation of adherence to titratable continuous insulin and heparin orders
Favorite
13-087 - Evaluation of adherence to titratable vasopressors
Favorite
13-383 - Evaluation of albumin 25% use for intradialytic hypotension (IDH)
Favorite
12-344 - Evaluation of albumin use at an academic medical center
Favorite
13-346 - Evaluation of albumin use in a community hospital system
Favorite
13-379 - Evaluation of alteplase for central venous catheter (CVC) patency
Favorite
13-276 - Evaluation of an electrolyte replacement protocol across a multi-hospital health system
Favorite
9-283 - Evaluation of an inpatient pharmacist-driven vancomycin dosing protocol; time within therapeutic trough range
Favorite
13-217 - Evaluation of an insulin infusion protocol for treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state at a community based teaching hospital
Favorite
11-304 - Evaluation of angiotensin-converting enzyme inhibitor or angiotensin receptor II blocker or angiotensin receptor-neprilysin inhibitor and beta-blocker guideline adherence prior to hospitalization for decompensated heart failure
Favorite
10-412 - Evaluation of antibiotic use in the emergency department after policy change and antimicrobial stewardship education
Favorite
13-083 - Evaluation of anticoagulant primary adherence post-discharge from a four-hospital community health system
Favorite
12-149 - Evaluation of apixaban and rivaroxaban utilization for acute venous thromboembolism at a Western Michigan community teaching hospital
Favorite
13-065 - Evaluation of appropriate antibiotic prescribing for spontaneous bacterial peritonitis (SBP) prophylaxis in hospitalized adult cirrhotic patients
Favorite
10-124 - Evaluation of appropriate erythropoiesis-stimulating agent (ESA) prescribing and usage in chronic kidney disease (CKD) hospitalized patients
Favorite
9-363 - Evaluation of appropriate use of anidulafungin in a pediatric hospital
Favorite
9-329 - Evaluation of appropriate use of oral direct factor Xa inhibitors in a health system
Favorite
11-322 - Evaluation of appropriateness of initiation of proton pump inhibitors in patients 65 years and older in a community hospital
Favorite
10-135 - Evaluation of appropriateness of medications continued after transfer to behavioral health units
Favorite
9-330 - Evaluation of appropriateness of novel beta-lactamase inhibitor combinations
Favorite
9-037 - Evaluation of aprepitant for the prevention of post-operative nausea and vomiting
Favorite
10-292 - Evaluation of beta-blocker prescribing practices and appropriate use for treatment of hypertension in adults 18 years and older in a federally qualified health center
Favorite
11-120 - Evaluation of blood factor product use in patients with hemophilia undergoing elective surgical procedures
Favorite
10-122 - Evaluation of bridging from an insulin drip to subcutaneous insulin detemir in patients with diabetic ketoacidosis
Favorite
10-062 - Evaluation of calcitonin use at an academic health system
Favorite
12-115 - Evaluation of calcitonin use following recent institutional guideline revisions
Favorite
10-083 - Evaluation of ceftaroline utilization in a large community hospital
Favorite
10-237 - Evaluation of clevidipine use following cardiothoracic surgery in a community hospital
Favorite
13-375 - Evaluation of coagulation factor product utilization in a community healthcare system
Favorite
11-173 - Evaluation of compliance to a pain, agitation, and delirium protocol in critically ill adults
Favorite
11-247 - Evaluation of compliance to current Clostridium difficile infection treatment guidelines
Favorite
13-419 - Evaluation of concomitant opioid and benzodiazepine prescribing patterns in a community pharmacy setting
Favorite
10-207 - Evaluation of cost and appropriate use of intravenous acetaminophen in the inpatient setting
Favorite
12-269 - Evaluation of darbepoetin alfa in an acute care teaching hospital
Favorite
13-208 - Evaluation of diclofenac patches for acute pain in critically ill trauma patients
Favorite
9-190 - Evaluation of dosing regimen of enoxaparin for venous thromboembolism prophylaxis in morbidly obese patients
Favorite
12-317 - Evaluation of dosing strategies for 4-factor prothrombin complex concentrate for urgent vitamin k antagonist reversal: a single center retrospective review
Favorite
11-439 - Evaluation of eculizumab usage in post-transplantation patients at Presbyterian/St. Luke's Medical Center
Favorite
11-180 - Evaluation of enoxaparin prophylaxis dosing in obese patients
Favorite
13-324 - Evaluation of ferumoxytol and sodium ferric gluconate complex as intravenous (IV) iron supplementation in a community tertiary care center: a retrospective analysis
Favorite
9-179 - Evaluation of FK506 concentrations in solid organ transplant patients at a pediatric institution
Favorite
12-151 - Evaluation of four-factor prothrombin complex concentrate (4F-PCC) utilization in a community teaching hospital
Favorite
11-440 - Evaluation of four-factor prothrombin complex concentrate for off-label indications in patients with liver disease
Favorite
10-293 - Evaluation of gabapentin prescribing for neuropathic pain in a federally qualified health center: a retrospective medication use evaluation
Favorite
13-190 - Evaluation of icatibant use for angioedema at a tertiary care hospital
Favorite
9-396 - Evaluation of initial treatment for clostridium difficile based on updated 2018 IDSA guidelines
Favorite
9-170 - Evaluation of injectable calcitonin use for the treatment of symptomatic hypercalcemia in adults
Favorite
11-367 - Evaluation of inpatient rituximab orders for appropriateness and optimization
Favorite
10-071 - Evaluation of inpatient utilization of naloxone at a community hospital
Favorite
9-002 - Evaluation of insulin infusion efficacy in non-DKA critically ill patients
Favorite
12-328 - Evaluation of insulin utilization in the treatment of hyperkalemia at a large academic medical center
Favorite
12-272 - Evaluation of intravenous (IV) levothyroxine use in adult inpatients
Favorite
12-410 - Evaluation of intravenous acetaminophen in a tertiary academic medical center emergency department
Favorite
9-063 - Evaluation of intravenous acetaminophen use in a large community hospital
Favorite
13-349 - Evaluation of intravenous acetaminophen use in the emergency department, operating room, and a medical-surgical floor across a major hospital system
Favorite
11-138 - Evaluation of intravenous phenytoin use in adult patients in the hospital setting
Favorite
9-140 - Evaluation of ketamine, lidocaine, and haloperidol as alternatives to opioids for pain management within the emergency department
Favorite
10-211 - Evaluation of liposomal bupivacaine versus non-liposomal bupivacaine on patient outcomes in total knee arthroplasty
Favorite
9-175 - Evaluation of mandated documentation of proton pump inhibitor indication in a computerized prescriber order entry (CPOE) system
Favorite
10-140 - Evaluation of meropenem use at a community teaching hospital
Favorite
12-189 - Evaluation of methadone and buprenorphine product prescribing within a hospital setting
Favorite
13-382 - Evaluation of missed antibiotic doses in hospitalized patients undergoing hemodialysis
Favorite
10-354 - Evaluation of naloxone and flumazenil as reversal agents in acute care hospitals
Favorite
9-416 - Evaluation of neonatal abstinence syndrome management and prescribing patterns
Favorite
10-314 - Evaluation of opioid prescribing practices and appropriate monitoring for use in chronic pain management at a federally qualified health center
Favorite
13-082 - Evaluation of oseltamivir prescribing in the emergency department during the 2017-2018 influenza season
Favorite
12-421 - Evaluation of oxycodone controlled-release tablet discharge orders at an academic medical center
Favorite
12-327 - Evaluation of Palivizumab Use for Respiratory Syncytial Virus (RSV) Prophylaxis in Pediatric Patients
Favorite
13-214 - Evaluation of periprocedural use of cangrelor in patients with antiplatelet requirements within a multi-hospital health system
Favorite
10-163 - Evaluation of pharmacist-directed interventions on meropenem usage and appropriateness at Mercy Health-Fairfield Hospital
Favorite
13-077 - Evaluation of post-operative pain control and opioid use in breast mastectomies with reconstruction after implementation of enhanced recovery after surgery (ERAS) pathway
Favorite
9-365 - Evaluation of potential cost savings with a dose rounding protocol for Antithymocyte Globulin agents
Favorite
10-236 - Evaluation of prescribing practice at hospital discharge: concurrent benzodiazepine and opioid prescriptions
Favorite
10-036 - Evaluation of prothrombin complex concentrate use in patients with bleeding events associated with warfarin, apixaban, or rivaroxaban at a community hospital
Favorite
9-001 - Evaluation of prothrombin complex concentrate utilization and associated hospital costs at an academic medical center
Favorite
11-310 - Evaluation of prothrombin complex concentrate utilization in a community health system
Favorite
13-138 - Evaluation of proton pump inhibitor electronic criteria for use form to guide appropriate prescribing
Favorite
12-423 - Evaluation of rabies vaccine usage at a rural community hospital
Favorite
13-418 - Evaluation of readmission rates of patients receiving basal insulin through an indigent medication program at a 455-bed community hospital
Favorite
13-325 - Evaluation of revenue integrity for blood factor products at a pediatric hospital
Favorite
12-255 - Evaluation of sacubitril/valsartan prescribing at a community hospital
Favorite
13-160 - Evaluation of sacubitril/valsartan’s utilization in an inpatient acute care hospital setting for patients with heart failure
Favorite
12-141 - Evaluation of safety and efficacy for a new weight based insulin order panel for hyperkalemia
Favorite
13-134 - Evaluation of sodium polystyrene sulfonate and lactulose for treatment of acute hyperkalemia
Favorite
10-240 - Evaluation of sugammadex usage at a tertiary medical center for neuromuscular blockade reversal
Favorite
13-348 - Evaluation of system wide use of alvimopan for the prevention of post-operative ileus (POI) in a community hospital
Favorite
13-086 - Evaluation of tapentadol prescribing compliance in a community hospital setting
Favorite
9-333 - Evaluation of Tetanus, Diphtheria and Pertussis (Tdap) vaccination usage in the emergency department of a level I trauma center
Favorite
9-368 - Evaluation of the adherence rate to the FDA restrictions on tramadol use in pediatric patients
Favorite
13-085 - Evaluation of the appropriate use of daptomycin in methicillin-resistant Staphylococcus aureus bacteremia and vancomycin-resistant Enterococcus systemic infections
Favorite
12-305 - Evaluation of the appropriate use of proton pump inhibitors and histamine-2 receptor antagonist in the intensive care unit (ICU) at St. Barnabas Health System (SBH)
Favorite
12-187 - Evaluation of the appropriate use of scheduled dexamethasone therapy in the neurologic population
Favorite
10-235 - Evaluation of the appropriate utilization of sugammadex for the reversal of neuromuscular blocking agents
Favorite
11-153 - Evaluation of the appropriateness of stress ulcer prophylaxis in non-emergency department inpatients
Favorite
11-199 - Evaluation of the compliance and impact of the meropenem restriction in a health system
Favorite
11-326 - Evaluation of the effectiveness of an inpatient pain order set to improve pain management
Favorite
13-040 - Evaluation of the efficacy of aprepitant administered as intravenous (IV) push in cancer patients
Favorite
10-381 - Evaluation of the off-label use of erythropoietin
Favorite
13-234 - Evaluation of the overall usage of ketamine in a non profit community hospital
Favorite
10-375 - Evaluation of the safety of propofol use for extended infusion in the ICU setting in a community hospital
Favorite
10-426 - Evaluation of the timing of second dose of antibiotics in sepsis patients within a community health system
Favorite
9-194 - Evaluation of the use of acid suppression therapy following the implementation of a policy
Favorite
9-084 - Evaluation of the use of alvimopan in a community hospital
Favorite
13-289 - Evaluation of the use of electronic criteria for use forms to guide appropriate antibiotic prescribing practices
Favorite
11-121 - Evaluation of the use of esmolol in adult patients at a tertiary, academic medical center
Favorite
10-396 - Evaluation of the use of Insulin at a community health network
Favorite
10-212 - Evaluation of the use of sugammadex in pediatric patients
Favorite
10-084 - Evaluation of the use of Tolvaptan at a Large Community Hospital
Favorite
13-328 - Evaluation of the utilization of intravenous immune globulin in an acute care children’s hospital
Favorite
10-072 - Evaluation of the utilization of sacubitril/valsartan in a community hospital setting
Favorite
13-091 - Evaluation of therapeutic monitoring of acetaminophen in infants less than one year old
Favorite
13-305 - Evaluation of tolvaptan utilization in a tertiary care hospital
Favorite
12-256 - Evaluation of total duration of antibiotics prescribed for treatment of urinary tract infections in a community hospital setting
Favorite
11-246 - Evaluation of unfractionated heparin continuous infusion protocol use in obese patients
Favorite
11-025 - Evaluation of use of sugammadex as anesthesia reversal
Favorite
11-249 - Evaluation of vancomycin dosing in hemodialysis patients
Favorite
11-198 - Evaluation of vancomycin dosing in patients undergoing hemodialysis in an academic medical center
Favorite
11-272 - Evaluation of vasopressin use based on current hospital practices in a community hospital setting
Favorite
12-184 - Experience using 4-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa Inhibitors in a large community hospital
Favorite
12-106 - Experience with concentrated regular insulin U-500 in transitions of care
Favorite
13-158 - Fosaprepitant (Emend®) for Prevention of Chemotherapy-Induced Nausea and Vomiting: A Medication Utilization Evaluation
Favorite
13-329 - Glucocorticoid dose evaluation for the treatment of acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients
Favorite
10-369 - Identifying risk factors linked to inpatient hypoglycemia at a community teaching hospital
Favorite
13-090 - Impact of a prepopulated, defaulted dispense quantity on emergency department opioid discharge prescriptions
Favorite
9-113 - Impact of a reduced concentration heparin purge solution on anti-Xa levels in patients on percutaneous mechanical support devices
Favorite
11-449 - Impact of drug shortages on a community hospital over a six month period
Favorite
9-409 - Impact of fixed-dose ketorolac on pain scores and utilization of additional pain medications in a community hospital
Favorite
11-110 - Impact of interprofessional monitoring and education on the usage of systemic glucocorticoids in acute exacerbations of COPD
Favorite
12-330 - Impact of intravenous push (IVP) versus intravenous piggyback (IVPB) administration time and outcomes in sepsis
Favorite
12-034 - Impact of OnabotulinumtoxinA on Healthcare Resource Utilization in Adult Patients with Chronic Migraine
Favorite
13-089 - Impact of perioperative administration of oral and IV tranexamic acid on postoperative blood loss in total hip arthroplasty and total knee arthroplasty
Favorite
9-143 - Impact of pharmacist-led clinical intervention in reducing intravenous vancomycin use at a community hospital
Favorite
10-351 - Impact of reduced basal insulin requirements on glycemic control during nothing by mouth (NPO) status
Favorite
11-308 - Impact of sepsis order set updates on carbapenem utilization in a community regional medical center
Favorite
9-342 - Implementation of a pharmacy-driven consult service: a vancomycin medication use evaluation
Favorite
13-341 - Implementation of a single formulary basal insulin product in a community hospital
Favorite
12-051 - Implementation of Epic SmartList to improve prescribing practices of albumin
Favorite
11-265 - Incidence of vancomycin nephrotoxicity: area under the curve dosing versus traditional dosing
Favorite
11-232 - Inpatient Prescribing Practices of Albumin in an Academic Medical Center
Favorite
11-196 - Inpatient utilization of methylene blue at a tertiary academic medical center
Favorite
13-205 - Intravenous haloperidol use in the acute care setting
Favorite
12-345 - Intravenous immunoglobulin use at an academic medical center: a retrospective observational study to validate current practice
Favorite
11-226 - Intravenous opioid de-escalation in general medicine patients
Favorite
13-196 - Is inappropriate documentation of penicillin allergy related to overuse of aztreonam?
Favorite
10-413 - Kit Check optimization (utilization review and cost analysis)
Favorite
9-141 - Medication use evaluation of albumin 25% in a community-based hospital
Favorite
10-073 - Medication use evaluation of alteplase in a community hospital
Favorite
9-286 - Medication use evaluation of alteplase in the management of acute ischemic stroke at Baptist Saint Anthony’s Health System
Favorite
9-343 - Medication use evaluation of antimicrobial prophylaxis in cardiac and vascular surgery at Memorial Hermann Southwest Hospital (MHSW)
Favorite
13-393 - Medication Use Evaluation of Appropriate Initiation and Discontinuation of Acid Suppressant Agents for Stress Ulcer Prophylaxis
Favorite
10-217 - Medication use evaluation of bupivacaine liposome injectable suspension in a community hospital
Favorite
12-274 - Medication use evaluation of calcitonin injection for hypercalcemia
Favorite
9-221 - Medication use evaluation of cangrelor in a tertiary care community hospital
Favorite
11-206 - Medication Use Evaluation of Collagenase in the NICU of a Small Community Hospital
Favorite
12-284 - Medication Use Evaluation of Dornase Alfa (Pulmozyme®) at a Large Academic Medical Center
Favorite
9-305 - Medication use evaluation of ertapenem in a community hospital
Favorite
12-119 - Medication use evaluation of hydroxocobalamin for vasoplegia following cardiac surgery
Favorite
11-257 - Medication use evaluation of intravenous acetaminophen in surgical patients
Favorite
9-332 - Medication use evaluation of intravenous acetaminophen within a multi-center county health system
Favorite
9-219 - Medication use evaluation of isoproterenol in the adult population of a tertiary medical center
Favorite
9-284 - Medication use evaluation of prokinetic agents for facilitation of gastric emptying in a community hospital
Favorite
9-169 - Medication Use Evaluation of Prothrombin Complex Concentrate
Favorite
9-150 - Medication use evaluation of prothrombin complex concentrate (PCC) and potentail impact of andexanet alfa
Favorite
9-334 - Medication Use Evaluation of sugammadex at a metropolitan health system
Favorite
11-117 - Medication use evaluation of systemic steroids for COPD exacerbations in the inpatient setting
Favorite
12-287 - Medication use evaluation of the transition from oral factor Xa inhibitors to unfractionated heparin
Favorite
13-397 - Medication use evaluation: antibiotic use for early-onset sepsis in neonates using the Kaiser Permanente neonatal early-onset sepsis risk calculator
Favorite
11-113 - Medication use evaluation: appropriate deprescribing and monitoring of proton pump inhibitors in the primary care setting
Favorite
11-115 - Medication use evaluation: appropriate duration of therapy of bisphosphonates in the treatment of osteoporosis
Favorite
11-207 - Medication use evaluation: dosage of vasopressin in septic shock at a rural academic medical center
Favorite
11-399 - Medication use evaluation: inpatient and outpatient intravenous iron usage and prescribing
Favorite
12-103 - Medication use evaluation: piperacillin-tazobactam use in the neonatal intensive care unit at an academic medical center
Favorite
11-114 - Medication use evaluation–sulfonylurea appropriateness and management within the primary care setting
Favorite
10-348 - Medication utilization evaluation of sugammadex at West Penn Hospital and Forbes Hospital to assess compliance with the Allegheny Health Network usage guideline
Favorite